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G E N E R A L I N T R O D U C T I O N 9 
A N D O U T L I N E OF T H E S T U D I E S 
Backgrounds 
Over the past decade proctocolectomy with ileal pouch-anal anastomosis has 
become the surgical treatment of choice for patients with ulcerative colitis or 
familial adenomatous polyposis. It enables the excision of the entire diseased 
io colon with preservation of continence and avoidance of a permanent ileosto-
my. However, surgical techniques and understanding of physiology of ileal 
pouch surgery are continuing to evolve. 
Ileal pouch surgery for ulcerative colitis and familial adenomatous polypo-
sis started in 1983 in the Department of Surgery of the University Hospital 
Nijmegen. In a review published in 1992 (chapter 3) we were struck by the 
high incidence of pouchitis. In the literature several explanations for pouchi-
tis are presented but none of these are entirely satisfactory. Among the expla-
nations suggested, bile acid deconjugation as a result of bacterial overgrowth 
in the ileal pouch is often quoted. In view of the the combined expertise of the 
Departments of Gastroenterlogy and Surgery, we selected to study several 
aspects of bile acid metabolism in ileal pouch-anal anastomosis patients. 
Introduction to bile acid metabolism 
In man, the primary bile acids cholic and chenodeoxycholic acid are synthesi-
zed in the liver as the major end products of cholesterol metabolism, and 
secreted into bile as glycine or taurine conjugates. Conjugated bile acids play 
an imprtant role in solubilizing biliary cholesterol and digestion of dietary 
fat. Bile acids undergo effective enterohepatic ciculation: under normal con-
ditions more than 95% is reabsorbed in the ileum per cycle. Only small 
amounts spill over into the colon and are deconjugated by the colonic bacte-
rial flora. After deconjugation the primary bile acids cholic and chenodeoxy-
cholic acid undergo bacterial 7a-dehydroxyIation and are converted into the 
secondary bile acids deoxycholic and lithocholic acid respectively. Further 
bacterial and hepatic transformation results in the production of tertiary bile 
acids (Figure 1.1). Deoxycholic acid is passively reabsorbed by the colonic 
mucosa and takes part in the enterohepatic circulation. Lithocholic acid is 
insoluble at body temperature and is largely excreted via the faeces. 
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Figure M Synthesis and transformation of the major bile acids. 
Outline of the studies 
II 
In Chapter 2 a review of the literature on the surgical and physiological 
aspects of proctocolectomy with ileal pouch-anal anastomosis is presented. 
In Chapter 3 the immediate postoperative and long-term functional results 
of ileal pouch-anal anastomosis for ulcerative colitis and familial adenoma­
tous polyposis are compared in all patients who underwent this procedure 
between 1983 and 1990 at the University Hospital Nijmegen. 
In Chapter 4 the influence of ageing on fasting and postprandial conjuga­
ted and unconjugated serum bile acid levels is studied. In previous studies it 
has been suggested that reabsorption of conjugated bile acids is less effective 
in elderly subjects. Spill-over of conjugated bile acids into the colon may lead 
to an increased formation of secondary bile acids. Since secondary bile acids 
are co-mutagenic and enhance colonic mucosal proliferation, a decreased 
ileal bile acid reabsorption may contribute to an enhanced risk of colonic can­
cer in elderly subjects. In this study postprandial conjugated serum bile acid 
levels appeared to be decreased in elderly subjects. Therefore, subjects should 
be age-matched in studies comparing postprandial serum bile acid levels. An 
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impaired reabsorption of bile acids may theoretically lead to an increased 
stool frequency in elderly subjects who have undergone ileal pouch-anal ana-
stomosis. 
In Chapter 5 the usefulness of fasting individual unconjugated serum bile 
acid levels in predicting small intestinal bacterial overgrowth is evaluated. 
12 The results were compared to those obtained in healthy controls, and in 
patients with other malabsorptive states. Patients who had undergone ileal 
pouch-anal anastomosis or ileal resection were also included as control 
groups since these conditions may theoretically predispose to elevated 
unconjugated serum bile acid levels as a result of stasis in the ileal pouch and 
spill-over into the colon respectively. 
In Chapter 6 the influence of proctocolectomy with ileal pouch-anal ana-
stomosis on conjugated and unconjugated serum bile acid levels is evaluated. 
This study provides evidence that reabsorption of conjugated bile acids and 
biotransformation of primary into secondary bile acids is impaired after 
proctocolectomy with ileal pouch-anal anastomosis. 
In animal studies it has been shown that colectomy may lead to elevated 
plasma cholecystokinin levels. This suggests that the colon contains a factor 
that inhibits the release of cholecystokinin from the proximal small intestine. 
In Chapter 7 plasma cholecystokinin levels and gallbladder volumes after 
proctocolectomy with ileal pouch-anal anastomosis are investigated in 
humans. This study showed that fasting and postprandial cholecystokinin 
levels are elevated after ileal pouch-anal anastomosis, and that fasting 
gallbladder volumes are decreased in these patients. 
In order to examine whether ileal resection leads to alterations in bile acid 
absorption, deconjugation, 7oc-dehydroxylation, and formation of urso-
deoxycholic acid, we studied fasting and postprandial conjugated and uncon-
jugated serum bile acid levels in patients who had undergone ileal resection 
for Crohn's disease. In addition, the effect of ileal resection on plasma chole-
cystokinin and gallbladder volume was evaluated since intraduodenal bile 
acids are known to modulate cholecystokinin release. This study, which is 
described in Chapter 8, provides further evidence that ileal resection leads to 
interruption of the enterohepatic circulation and that the formation of 
deoxycholic acid is greatly reduced, whereas the formation of ursodeoxycho-
lic acid is increased in these patients. Ileal resection does not alter cholecysto-
kinin release and gallbladder motility. 
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C L I N I C A L A N D P H Y S I O L O G I C A L A S P E C T S O F 13 
I L E A L P O U C H - A N A L A N A S T O M O S I S 
Jan M.J.I. Salemans and Fokko M. Nagengast. 
From the Division of Gastroenterology, Department of Medicine, 
University Hospital Nijmegen, The Netherlands. 
Scand) Gastroenterol 1995; 30 Suppl m: 3-12 
2.1 Introduction 
Proctocolectomy with ileal pouch-anal anastomosis (IPAA) is the surgical 
treatment of choice for severe chronic ulcerative colitis and familial adeno-
matous polyposis because the entire colonic mucosa is removed while anal 
14 function can be preserved and the necessity for permanent ileostomy is elimi-
nated. Long-term functional results are generally gratifying since defecation 
frequency and degree of incontinence are acceptable in most patients. 
Pouchitis however, a non-specific inflammation of the ileal reservoir, is a 
major long-term complication occurring in a considerable number of 
patients. The etiology of pouchitis is unknown. Since pouchitis occurs more 
frequently, or even exclusively in ulcerative colitis patients it is supposed that 
pouchitis is a novel manifestation of inflammatory bowel disease. In this 
review the postoperative and long-term functional results, recent surgical 
developments, histological aspects, and physiological changes after pouch 
surgery are discussed. 
2.2 Postoperative complications after ileal pouch-anal 
anastomosis 
Although the mortality of proctocolectomy with IPAA is lower than 0.5% in 
the largest series (1-5), there is a substantial postoperative morbidity. The 
commonest major postoperative complications include anastomotic strictu-
re, pelvic sepsis, fistula, and small bowel obstruction. 
Anastomotic stricture — The reported incidence of anal strictures following 
IPAA varies between 8% and 15% (2,6,7). Most of the strictures respond 
favourably to a single dilatation. Repeated dilatations for recurrent strictures 
however, may result in incontinence. Recurrent strictures may increase the 
risk of pouchitis (8). 
Pelvic sepsis — The incidence of pelvic sepsis following IPAA varies between 
5% and 20% (1,3,7,9-11). Pelvic sepsis may result from anastomotic 
dehiscence or disruption of the suture line. Cuff abscess was the most com-
mon cause of pelvic sepsis at the time surgeons used to leave a rectal cuff 
through which the pouch was pulled down. Since the introduction of the 
stapled IPAA, which does not involve a rectal cuff, this complication has been 
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eliminateci. Pelvic sepsis is the most common cause of pouch failure and 
results in pouch excision in approximately 5-10% of patients (7,11-13). 
Pouch-ua,ginal and pouch-perianal jistula — The reported incidence of pouch-
vaginal fistula varies between 7 and 11% (2,14,15). In a North-American mul-
ticentre study (14), 21 (7%) out of 304 women who underwent IPAA develo- 15 
ped pouch-vaginal fistulas. Patients who had previously undergone subtotal 
colectomy for fulminant ulcerative colitis, or underwent IPAA on an urgent 
basis, as well as those who ultimately appeared to have Crohn's disease, and 
those who were operated without a temporary diverting loop ileostomy were 
at an increased risk of this complication. Twenty percent of these patients 
required pouch excision. In a study from St. Mark's Hospital in London, 17 
(11%) out of 161 women developed a pouch-vaginal fistula(i5). Postoperative 
pelvic sepsis and previous subtotal colectomy were associated with an incre-
ased risk. Eight patients (47%) required pouch excision. A variety of surgical 
procedures may be used to treat pouch-vaginal fistulas. Temporary ileal 
diversion alone is usually unsuccessful and should be combined with some 
sort of local treatment including transanal or transvaginal closure, 
sphincteroplasty, endoanal advancement flaps, or gracilis muscle interposi-
tion (14-16). However, the treatment of choice remains to be established. 
Fistulas from the ileal reservoir to the perianal area occur in approximately 
5% of patients (2,17). 
Small bowel obstruction — Small bowel obstruction is the most common early 
complication occurring in approximately 15-20% of patients undergoing 
IPAA (1,5,9,13,18,19). Approximately half of these patients require surgical 
intervention (20). The majority of episodes of small bowel obstruction occur 
after ileostomy closure. 
2.3 Long-term results after ¡leal pouch-anal anastomosis 
Functional results of IPAA tend to improve during the first year of follow-up, 
probably as a result of an adaptive process. The mean daily stool frequency 
declines from approximately 10 after one month to 7 after one year (4,5,13,21-
23). Between 1 and 10 years after ileostomy closure stool frequency and rate of 
fecal incontinence remain unchanged (24). 
The largest series with the longest follow-up to date on the quality of life 
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after IP AA has been reported by Kohler et al. (25) from the Mayo Clinic. They 
randomly selected 240 patients from 971 patients with chronic ulcerative coli-
tis who had undergone IPAA between 1982 and 1989 (30 patients each year) 
for an assessment of their long-term functional results and quality of life. 
Hundred-sixty patients undergoing cholecystectomy in the same period (20 
16 patients per year) served as controls. IPAA patients had more frequent stools 
and more fecal spotting than cholecystectomy patients. In spite of the altered 
bowel habits, 90% of IPAA patients had an excellent overall quality of life. 
Results were similar to patients who had undergone cholecystectomy. More-
over, quality of life and bowel habits remained steady in both groups of 
patients during the 8-year follow-up. 
The presenting disease has a major impact on the incidence of postopera-
tive complications and functional outcome. Several studies have compared 
the postoperative and long-term functional results of IPAA in patients with 
ulcerative colitis and familial adenomatous polyposis (5,8,13,26,27). The 
results of these studies are summarized in Table 2.1. Colitis patients tend to 
have a higher overall complication rate and more pouch-related septic com-
plications. In most studies the long-term functional results are better in poly-
posis patients. Tjandra et al. (27) however, found very similar functional out-
comes after IPAA in polyposis patients and ulcerative colitis patients. They 
studied 39 pairs of patients, individually matched for surgeon, technique of 
IPAA, duration of follow-up after pouch construction, age, and gender. The 
major difference between both groups was that pouchitis occurred more fre-
quently in colitis patients than in polyposis patients. 
2.4 Influence of pouch design on functional outcome 
In an attempt to improve functional results after restorative proctocolectomy 
several pouch designs have been developed: the duplicated J-pouch, the rare-
ly used lateral isoperistaltic pouch, the triplicated S-pouch, and the quadru-
plicated W-pouch. Nicholls and Pezim (28) compared functional outcome in 
88 patients who had undergone IPAA with three different pouch designs (12 
J-, 58 S-, and 18 W-pouches). Stool frequency was significantly higher in 
patients with J-pouches compared to those with W-pouches or S-pouches. 
Overall, there was an inverse relationship between reservoir volume and defe-
cation frequency. J-pouches were significandy smaller than the other two 
designs. All patients with J- or W-pouches defecated spontaneously whereas 
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only 41 percent ofthose with S-pouches did so. Sagar et al. (29) compared 
functional outcome between 20 patients with S- and 20 with W-pouches and 
found that the mean stool frequency in patients with W-pouches (3.5 per day) 
was significantly lower compared to those with S-pouches (6.0 per day). 
Patients with W-pouches had a greater efficiency of evacuation and their pou-
18 ches were more capacious compared to those with S-pouches. In a study by 
Nasmyth et al. (30) defecation was less frequent in patients with S-pouches 
compared to patients with J-pouches. However, de Silva et al. (31) found no 
significant differences in stool frequency, degree of continence or urgency 
between 23 patients with J-pouches, 15 with S-pouches, and 23 with W-pou-
ches, although patients with J-pouches required antidiarrhoeal medication 
more frequently compared to those with S- or W- pouches. Only 7 out of 15 
patients with S-pouches could defecate spontaneously compared to 22 with 
W-pouches and all patients with J-pouches. Keighley et al. (32) compared 33 
consecutive patients who were randomly allocated to reconstruction using a 
stapled J-pouch or a sutured W-pouch. The operation time was significantly 
shorter for J-pouches compared to W-pouches. The median daily stool fre-
quency was similar in both groups. There was no incontinence, urgency or 
soiling in both groups. 
In conclusion, the results of studies comparing the functional results of 
the different pouch designs are conflicting. However, stool frequency after 
IPAA seems to be inversely related to pouch capacity and tends to be lower 
with S- and W-pouches. On the other hand, operation time is longer and ope-
rative technique more complicated with the sutured S- and W-pouches com-
pared to the stapled J-pouch. Spontaneous evacuation is impaired in a consi-
derable percentage of patients with S-pouches. For these reasons the J-pouch 
is the most widely applied design. 
2.5 Subtotal colectomy prior to ileal pouch-anal anastomosis 
IPAA is usually carried out in two stages: the first operation consists of proc-
tocolectomy, construction of the pouch, and a temporary diverting loop ileo-
stomy. In the second operation, after a few months, the ileostomy is closed. 
However, IPAA is sometimes performed as a delayed procedure after subtotal 
colectomy with either ileorectal anastomosis (in polyposis patients), Hart-
mann's procedure and ileostomy, or ileostomy and sigmoidostomy (in ulce-
rative colitis patients), prior to proctectomy and construction of the pouch. 
CHAPTER 2 
Cases of Crohn's disease presenting as 'indeterminate' colitis, can be recog-
nized and excluded from pouch surgery. There has been debate as to whether 
delayed IPAA results in a lower postoperative complication rate and superior 
functional results, especially in malnourished patients with active ulcerative 
colitis receiving a high dose corticosteroids. A three stage procedure howe-
ver, carries a number of disadvantages, including an increased number of 19 
operations, a longer hospital stay, and a higher cost. 
Recent studies comparing the outcome of two-stage and three-stage IPAA 
are summarized in Table 2.2 (9,33-35). Galandiuk et al. (33) found that pre-
vious subtotal colectomy does not result in a decrease in postoperative com-
plications overall, and that there is no functional advantage compared with 
the two-stage procedure. Therefore, they concluded that, in experienced 
hands, two-stage IPAA is the preferred approach in most patients with ulce-
rative colitis. However, this subject remains controversial, since Penna et al. 
(35) found lower rates of postoperative complications with the three-stage 
procedure. The functional outcome was similar in both groups. Since subto-
tal colectomy prior to IPAA did not comprise the results of this procedure, 
they argued that the three-stage procedure is valuable in a subset of patients, 
including those with steroid-resistant colitis. 
In our experience (13), patients who had undergone subtotal colectomy 
prior to the ileal pouch procedure were at high risk for pouch failure. When 
all patients who had undergone subtotal colectomy prior to IPAA (n=27) were 
compared to the patients with a two-stage IPAA (n=45) the number of excised 
pouches was n (41%) and 1 (2%) respectively (p<o.ooi). 
In conclusion, the results of these studies are somewhat contradictory, but 
they suggest that there is no advantage of subtotal colectomy prior to IPAA in 
patients who can be operated electively and when Crohn's disease can be 
excluded. Functional results are similar after two- and three-stage IPAA. 
CHAPTER 2 
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2.6 Surgical procedures: recent developments 
Handstwn versus stapled ileal pouch-anal anastomosis — The classical pelvic 
pouch procedure (36,37) included transanal mucosectomy, a long rectal 
muscular cuff and a handsewn ileoanal anastomosis. In order to improve 
functional outcome and to reduce the incidence of postoperative anastomotic 21 
complications the stapled IPAA was introduced (38). This procedure avoids 
the time consuming mucosal proctectomy and leaves 1-2 cm of rectal mucosa 
(transitional zone) proximal to the dentate line to facilitate the ileoanal ana-
stomosis. 
Several groups have compared the clinical outcome of handsewn IPAA 
with mucosectomy versus stapled IPAA without mucosectomy (10,12,39). 
Wettergren et al. (12) studied 144 consecutive patients who underwent either 
handsewn (n=g6) or stapled (n=48) J-pouch ileoanal anastomosis. The per-
centage of anastomotic leaks was similar in both groups (13% versus 15%) as 
was the percentage of pouches that were removed because of postoperative 
complications (5% versus 6%) but the incidence of anastomotic stenosis was 
significantly higher in patients with a handsewn anastomosis (23%) compa-
red to those with a stapled anastomosis (6%). Two prospective, randomized 
studies (10,39) a ' s o showed a similar complication rate and similar function-
al results after either handsewn IPAA with mucosectomy or stapled IPAA wit-
hout mucosectomy. The authors of these studies concluded that double-stap-
led IPAA does not offer any functional or technical advantage over hand-sutu-
red anastomosis and they preferred full mucosectomy since the complete dis-
eased colonic mucosa is removed. 
The risk of cancer in the small segment of remaining rectal (transitional) 
mucosa after stapled IPAA does not seem to be very high, but follow-up is too 
short to draw firm conclusions. Persisting disease activity, dysplasia, and 
cancer in the remaining rectal mucosa have been documented in a few 
patients (40,41). Schmitt et al. (42) studied the incidence of inflammation 
and dysplasia in retained rectal mucosa after double-stapled IPAA for ulcera-
tive colitis. They evaluated 56 patients who had undergone double-stapled 
IPAA with a mean of 1 cm of rectal epithelium left above the dentate line. No 
evidence of dysplasia was found in any of the biopsy specimens just above the 
dentate line, and the distal resection line revealed active ulcerative colitis in 19 
(35%) patients. Only one of these patients experienced symptoms referable to 
active colitis. 
Regeneration of rectal mucosa after rectal mucosectomy and IPAA could 
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not be demonstrated in pathologic specimens obtained from patients who 
had required pouch excision (43). 
Temporary diverting ileostomy — Until recently a temporary defunctioning loop 
ileostomy has been employed routinely in patients undergoing IPAA in order 
22 to reduce the risk of anastomotic leakage and pelvic sepsis. However, the ile-
ostomy itself and its closure may be a source of significant complications 
(13,44-50). Moreover, ileostomy closure prolongs total hospital stay (44,45). 
Table 2.3 summarizes a number of studies comparing clinical outcome of 
IPAA with and without temporary diverting ileostomy. Cohen et al. (46) com-
pared the surgical complication rate and outcome of483 consecutive patients 
who had undergone IPAA performed with or without loop ileostomy. Three-
hundred-twenty-five patients had a handsewn anastomosis with ileostomy, 
87 had a stapled IPAA with ileostomy, and 71 patients had a stapled anasto-
mosis without ileostomy. The rate of anastomotic leakage was significantly 
reduced in patients with a stapled IPAA with ileostomy compared with those 
with a handsewn anastomosis and ileostomy. The omission of the ileostomy 
was associated with a higher incidence of anastomotic leaks, but spontane-
ous healing occurred in almost all patients. Patients on steroids and patients 
who had undergone a true one-stage procedure, had a greater risk of anasto-
motic leakage. Functional results were excellent in all groups, even in the 
patients who had had an anastomotic leak. 
In a prospective randomized study Grobler et al. (44) assessed the role of 
temporary ileostomy in patients receiving a stapled IPAA. Patients using ste-
roids were excluded. The incidence of anastomotic leakage, pelvic sepsis, 
bowel obstruction and pouchitis were similar in patients with or without 
temporary ileostomy. Approximately half of the patients in the ileostomy 
group developed ileostomy-related complications and total hospital stay was 
longer with ileostomy. 
In a non-randomized way Sagar et al. (45) similarly compared the clinical 
outcome after stapled IPAA with or without temporary ileostomy. In this 
study the use of high dose corticosteroids was no contraindication to ileosto-
my omission. The decision for or against temporary ileostomy was made 
during the procedure based on urgency, toxaemia, anastomotic tension, and 
integrity of the anastomoses. Avoidance of the ileostomy did not lead to an 
increased incidence of pelvic sepsis. The total hospital stay (including the 
hospitalization for ileostomy closure) was significantly reduced in the group 
of patients without an ileostomy. 
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In a study by Tjandra et al. (51) anastomotic leakage, pelvic abscess, and sep-
tic complications requiring relaparotomy were more common after IPAA wit-
hout ileostomy, compared to a carefully matched control group of patients 
with ileostomy. Patients using high dose corticosteroids had an increased 
risk of complications. Functional results were similar in both groups. Suger-
man and Newsome (52) however, found fewer acute complications and bet- 23 
ter stool control in patients with a stapled IPAA without ileostomy compared 
to a control group of patients with mucosectomy, handsewn IPAA, and tem-
porary ileostomy. 
In conclusion, omitting a temporary loop ileostomy does probably not 
lead to an increased number of pouch failures, at least in a group of well 
selected patients. In general, functional results are similar in patients who are 
operated without ileostomy compared to those without ileostomy. Whether 
the use of corticosteroids at the time of surgery increases the risk of anasto-
motic leaks is still matter of debate since data are scarce and conflicting. A 
temporary loop ileostomy itself is associated with a high incidence of compli-
cations and prolonged hospital stay. 
2.7 Ileal pouch-anal anastomosis in 'indeterminate colitis' and 
Crohn's colitis 
IPAA is generally considered contraindicated in patients with Crohn's disease 
because of the high risk of pelvic sepsis, fistulas, and pouchitis. However, 
preoperative distinction between ulcerative colitis and Crohn's colitis may be 
difficult, if not impossible. Occasionally, macroscopic and microscopic 
features of both ulcerative colitis and Crohn's colitis occur in the same 
patient. In such cases of 'indeterminate colitis', it is difficult to decide 
whether IPAA should be performed. 
In a retrospective analysis of 514 colitis patients who had undergone IPAA, 
Pezim et al. (54) compared the outcome of 25 (5%) patients who had features 
of indeterminate colitis with that of 48g ulcerative colitis patients. No 
significant differences in complication rate, pouch function, incidence of 
pouchitis, or pouch excision rate were found between the two groups. 
The outcome of IPAA in patients who were operated upon for presumed 
ulcerative colitis but ultimately were found to have Crohn's disease has been 
described by several groups. Hyman et al. (55) reviewed the records of 362 
ileal pouch patients with a preoperative diagnosis of ulcerative colitis and 
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Table 2.3.2 Conclusions, comments. 
Jarvinenand 
Luukkonen (53) 1991 
Crobleretal. (44) 1992 
Sagar et al. (45)1992 
Cohen et al (46) 1992 
Tjandraetal. (51) іддз 
Sugerman and 
Newsome (52) 1994 
Incidence of complications and functional results similar in 
both groups, hospital stay shorter without ileostomy. 
Incidence of complications and functional results similar in 
both groups, hospital stay shorter without ileostomy. 
Incidence of complications similar in both groups, hospital 
stay shorter in patients without ileostomy. 
Higher incidence of anastomotic leaks in patients without ile­
ostomy and in those taking steroids. 
Higher incidence of anastomotic leaks in patients taking ste­
roids, functional results similar in both groups. 
Incidence of complications and functional results similar in 
both groups, hospital stay shorter without ileostomy. 
25 
analyzed the outcome of 25 (7%) patients who were postoperatively proven to 
have Crohn's disease. Sixteen patients had a functioning pouch, seven had 
required pouch excision, one was diverted, and one had died. In a subgroup 
of nine patients in which there was a clinical feature suspicious for Crohn's 
disease preoperatively, eight patients had their pouch removed (p<o.oi). 
Deutsch et al. (56) reported on 9 (3%) out of 272 patients who appeared to 
have Crohn's disease. Four patients had eventually their pouches removed, 
five patients had functioning pouches: three with no complications and two 
with persistent perianal disease. Grobler et al. (57) found a marginally higher 
complication rate in 20 patients with pathological features of Crohn's disea­
se. Pouch excision or a persistent stoma was necessary in 30% of patients 
with Crohn's disease compared to 15% in patients with definite ulcerative 
colitis. However, functional results were acceptable if the pouch could be 
retained. These data demonstrate that patients with Crohn's colitis have an 
increased risk of complications and pouch failure. Therefore, IPAA should 
not knowingly be performed in these patients. 
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2.8 Pouchitis 
Ileal pouch inflammation or pouchitis is one of the major long-term compli-
cations of IPAA. Clinically, pouchitis is characterized by increased stool fre-
quency, bleeding, abdominal pain, and systemic symptoms such as fever, 
26 arthralgia, fatigue and weight loss. There is much confusion surrounding 
pouchitis because the syndrome has not been tightíy defined. The reported 
incidence of pouchitis varies widely between 7% and 42% (1,4,5,8,13,58-65). 
This variation can partly be explained by the use of different criteria (endosco-
pic and histologic confirmation) to establish the diagnosis (Table 2.4). 
Therefore, it has been proposed that the definition of pouchitis should inclu-
de endoscopic (increased vascularity, bleeding, ulceration) and histopatholo-
gical (acute inflammation, ulceration, chronic changes) criteria (66-68). The 
incidence of pouchitis tends to increase with prolonged follow-up, as is 
shown in successive reports from the Mayo Clinic (1,58,65) (Table 2.5). 
Table 2.4 Incidence of pouchitis. 
study number of incidence of diagnosis 
patients pouchitis clinical endoscopy biopsy 
Becker and Raymond (5) 100 18(18%) + + 
Salemans et al. (13) 72 19 (30%) + + 
Dayton et al. (26) 277 45 (16%) + 
Tjandra et al. (27) 78 17 (22%) + 
de Silva et al. (31) 61 13 (21%) + + 
Lohmulleretal. (58) 734 212(29%) + 
Rauhetal. (69) 215 30(14%) + + 
Mc Mullen et al. (70) 73 "(15%) + 
Schoetzetal. (71) 104 7(7%) + 
Fonkalsrud et al. (72) 145 34(23%) + 
Penna et al. (73) 41 0(0%)' 
1
 = this study included only familial adenomatous polyposis patients 
The etiology of pouchitis is unknown. It has been suggested that pouchitis is 
the result of bacterial overgrowth, particularly of anaerobic bacteria, secon-
dary to stasis in the ileal pouch (74-77). The generally satisfactory response to 
treatment with metronidazole supports this hypothesis. However, bacterial 
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overgrowth alone is probably not sufficient to explain pouchitis, since bacte-
rial overgrowth is present in virtually all pouches. Moreover, quantitative cul-
tures of pouch effluents did not show higher bacterial counts in patients with 
pouchitis compared to those without pouchitis (74,78,79). 
Ruseler-van Embden et al. (80) recently investigated the composition of 
ileal reservoir microflora in patients with and without pouchitis. An in-
creased number of aerobes and a decreased ratio of anaerobes to aerobes in 
patients with pouchitis was found compared to those without pouchitis. 
Since anaerobes are largely responsible for the production of short-chain 
fatty acids, this microbial imbalance may explain the markedly decreased 
amounts of short-chain fatty acids in output from patients with pouchitis 
(81). Short-chain fatty acids, especially butyrate, are considered to be the 
major source of energy for colonic epithelium. Since the pouch epithelium 
undergoes colonic metaplasia (64,78), lack of short-chain fatty acids might 
result in mucosal damage. Irrigation of the pouch with short-chain fatty acids 
has shown to be beneficial in patients with pouchitis (82). 
Several authors have suggested that pouchitis is a novel manifestation of 
inflammatory bowel disease persisting after total colectomy with IPAA 
(58,64,66,83-85). In most large series (8,58) pouchitis is more common in 
patients with ulcerative colitis than in those with familial adenomatous poly-
posis, and indeed may well be restricted to colitis patients (5,13) (Table 2.6). 
Only a few cases of pouchitis in familial polyposis patients have been repor-
ted by the Mayo Clinic (8,58) but these cases were poorly documented since 
endoscopy and histological confirmation was not performed in these 
patients. The presence of backwash ileitis in ulcerative colitis patients does 
not seem to predispose to later development of pouchitis, and an inflamed 
terminal ileum is not considered a contraindication for IPAA in ulcerative 
colitis patients (86). 
27 
Table 2.5 Increasing incidence of pouchitis with prolonged follow-up. The Mayo 
Clinic experience. 
study year of 
publication 
Metcalfetal. (65) 1985 
Pemberton et al. (1) 1987 
Lohmulleret al. (58) 1990 
number of 
patients 
188 
390 
734 
incidence of 
pouchitis 
15 (8%) 
55 (14%) 
212 (29%) 
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Pouchitis is associated with the development of conditions such as 
arthritis, iridocyclitis, erythema nodosum, and pyoderma gangrenosum, 
which are characteristic extracolonic manifestations of ulcerative colitis 
(58,83,87). These findings suggest that immunological mechanisms play a 
role in the pathogenesis of pouchitis. Lohmuller et al. (58) found that 
28 patients with extraintestinal manifestations of inflammatory bowel disease 
are at higher risk of pouchitis than patients who never had extraintestinal 
manifestations. This may have implications for the selection of colitis 
patients for IPAA. 
Transient mucosal ischemia may cause oxygen-derived free radical pro-
duction by xanthine oxidase, precipitating pouchitis after IPAA. Therefore, 
Levin et al. (88) studied the effect of allopurinol, a xanthine oxidase inhibitor, 
in patients with acute and chronic pouchitis. Acute pouchitis resolved 
promptly in four of eight patients. Seven of the 14 patients with chronic 
pouchitis responded completely with no recurrence of symptoms during tre-
atment. Thus, allopurinol either terminated an episode of acute pouchitis or 
prevented pouchitis from recurring in 50 percent of patients. These data sup-
port a role for mucosal ischemia and oxygen free radical production in the 
etiology of pouchitis. 
Pouchitis usually responds favourably to treatment with metronidazole 
orally or rectally. However, recurrence rates are as high as 60% (31,58). Suc-
cessful treatment of pouchitis with sulfasalazine (69), topical 5-aminosalisy-
lic acid (89), topical or systemic steroids (31,69), and short-chain fatty acids 
irrigation (82) has been reported in patients who do not respond to metronid-
azole. However, until now, no controlled trials comparing medical treat-
ments have been reported. 
In conclusion, pouchitis is a major long-term complication after IPAA. 
Since pouchitis is probably confined to patients operated upon for ulcerative 
colitis, it is likely that pouchitis is a novel manifestation of inflammatory 
bowel disease. Luminal and microbiological factors may play a supplementa-
ry role in its pathogenesis. 
2.9 Histopathological alterations in ileal pouches 
Shepherd et al. (64) studied mucosal biopsy specimens from the ileal reser-
voirs of 92 patients who had undergone restorative proctocolectomy. Chronic 
inflammation (infiltration with lymphocytes and eosinophils) was found in 
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almost all, as was villous atrophy of varying severity. Acute inflammatory 
changes (infiltration with polymorphs) and ulceration were associated with 
pouchitis. The severity of acute inflammation was increased in ulcerative coli-
tis patients compared to those with familial polyposis and pouchitis was pre-
sent only in patients who had had ulcerative colitis. Although the mucosa of 
some ileal pouches acquire certain colonic characteristics, complete colonic 29 
metaplasia does not occur (go). The proportions of epitheloid cells and tingi-
ble body macrophages have been found to be increased in pouches with 
pouchitis compared to pouches without pouchitis or normal ileum (91). 
Since an increase of these macrophage subpopulations are characteristic of 
inflammatory bowel disease, their presence in pouchitis suggests that ulcera-
tive colitis and pouchitis have similar pathogenetic mechanisms. 
2.10 Sexual function and pregnancy 
The most common sexual complication in males after IPAA is retrograde eja-
culation, which occurs in 1-10% of men, whereas impotence has been repor-
ted in up to 1.5% (5,61,92,93). 
Sexual function in women after restorative proctocolectomy has been stu-
died by Metcalf et al. (94). Fifty women with a continent ileostomy (Kock's 
pouch) and 50 women with IPAA were interviewed regarding their preopera-
tive and postoperative sexual function. Frequency of intercourse increased 
and the incidence of dyspareunia decreased after operation in both groups. 
Only one patient in each group reported a postoperative disturbance in ability 
to achieve orgasm. Overall, the majority of women in this study experienced 
enhanced sexual function after operation, which they attributed mainly to 
improved health. 
Nelson et al. (95) described 20 women who underwent IPAA and subse-
quendy had at least one successful pregnancy and delivery. Eleven deliveries 
were vaginal with episiotomy, and nine were cesarean sections. No maternal 
deaths occurred. The frequency of nocturnal stooling increased in the IPAA 
patients during pregnancy, and the increase persisted for three months after 
delivery. In contrast, the frequency of daytime stools and the incidence of 
incontinence were not greatly altered by pregnancy or delivery. Moreover, 
postpartum pouch function was not influenced by the type of delivery. There-
fore, normal pregnancy appears to be possible after IPAA. However, the route 
of delivery should be individualized in these patients. 
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2.11 Physiological aspects of ileal pouch-anal anastomosis 
Bile acid metabolism — The fecal bile acid output is increased in ileal pouch 
patients compared to healthy, non-colectomized volunteers (96,97). Reten-
tion of ^ Se-taurohomocholate (SeHCAT) is decreased in these patients com-
30 pared to nonoperated colitis patients (98) or healthy controls (99,100). 
Postprandial conjugated bile acid levels increase to a lower extent in ileal 
pouch patients compared to healthy subjects (101). Therefore, reabsorption 
of bile acids is impaired after IPAA. Bile acid malabsorption might be expec-
ted in these patients for several reasons. Firstly, the mucosa of ileal pouches 
show histologic signs of inflammation in the vast majority of patients (66). 
Secondly, reabsorption of bile acids may be impaired since the relative muco-
sal surface of the terminal ileum is smaller after construction of a reservoir. 
Finally, stasis in the ileal pouch may lead to deconjugation of bile acids as a 
result of bacterial overgrowth. Bile acid malabsorption may lead to altera-
tions in bile composition and saturation index. Therefore, the risk of gall-
stone formation may be increased in ileal pouch patients. To assess the 
influence of colectomy on bile composition and saturation index Harvey et al. 
(102) collected bile samples at the time of abdominal surgery in patients with 
ulcerative colitis before or after colectomy. The precolectomy group consis-
ted of 17 patients who were sampled at the time of colectomy. The postcolec-
tomy group consisted of 11 patients who had undergone (sub)total colectomy 
previously (and were operated upon for conversion from conventional ileo-
stomy to a pelvic pouch or other reasons). The bile composition in the preco-
lectomy group was similar to control patients without gallstones, and few 
had crystals in their bile. In the postcolectomy group, cholesterol concentra-
tions were very high, all biles were supersaturated, and almost all patients 
had cholesterol crystals in their bile. However, to date there is still no eviden-
ce that patients with an ileal pouch are at greater risk for cholelithiasis. 
Water and electrolyte balance — Changes in water and sodium balance after 
IPAA are similar to those after conventional ileostomy. Santavirta et al. (103) 
studied water and electrolyte balance in 30 patients with IPAA, 10 patients 
with conventional ileostomy, and 9 nonoperated patients with quiescent 
ulcerative colitis. Daily urinary excretion of sodium in nonoperated patients 
was significantly higher than in patients with an ileal pouch or conventional 
ileostomy. Daily fecal weight, urinary volume, and urinary excretion of sodi-
um were similar in patients with IPAA and conventional ileostomy. Using tri-
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tïated water and a bromide dilution technique, Christie et al. (104) showed 
that the body content of water and extracellular fluid are normal in patients 
with IPAA. 
Malabsorption — Hylander et al. (105) found moderate steatorrhoea in 
approximately 30% of patients three months after ileostomy closure, but 31 
fecal fat excretion normalized with time. The absorption of carbohydrates, 
amino acids, and bile acids by the ileal pouch mucosa after proctocolectomy 
with IPAA has been found to be markedly decreased compared to normal 
ileum (106). Impaired intestinal absorption of D-xylose and low serum iron 
levels have been reported in ileal pouch patients. Nevertheless, clinical signs 
of malnutrition or malabsorption rarely occur in these patients (100). Low 
vitamin B12 levels and decreased Schilling tests have been found in IPAA 
patients (78,97,105). Bacterial overgrowth in the pouch may contribute to 
vitamin B12 malabsorption, since some microbial species utilize dietary vita-
min B12 from the host. 
Motility of the small intestine — Soper et al. (107) found that small bowel transit 
is markedly slowed in most patients after proctocolectomy with IPAA compa-
red to conventional ileostomy or healthy non-colectomized subjects. Howe-
ver, gastric emptying of liquids is not altered in these patients (107). Installa-
tion of oleic acid in the ileal pouch slows gastrointestinal transit and increa-
ses plasma levels of peptide-YY, neurotensin and enteroglucagon (108). 
These hormones are believed to play a role in the adaptive response after large 
bowel resection. Basal and postprandial plasma levels of peptide-YY have 
been reported to be increased after IPAA compared to healthy controls (109). 
Infusion of peptide-YY induces a dose related inhibition of mouth to caecum 
intestinal transit time and of the rate of gastric emptying (no). These data 
suggest that peptide-YY may play a major role in the adaptive response of the 
intestine to proctocolectomy with pouch construction. 
Fasting and postprandial plasma cholecystokinin levels are elevated and 
fasting gallbladder volumes are decreased after proctocolectomy with IPAA 
in humans (in). These findings suggest that the colon contains a factor that 
inhibits the release of cholecystokinin. 
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2.12 Cenerai conclusions 
Proctocolectomy with IPAA has become the treatment of choice for severe 
ulcerative colitis and familial adenomatous polyposis. The procedure should 
not knowingly be performed in patients with Crohn's colitis. The procedure 
32 carries a low mortality but a considerable morbidity. The surgical procedure 
has become less complicated and less time consuming since the introduction 
of stapling devices. However, the complication rate has not declined appa-
rently. Without mucosectomy some transitional and rectal mucosa is left 
behind and uncertainty remains as to whether these patients are at risk of dys-
plasia and cancer. Using the stapling techniques, omission of the temporary 
loop ileostomy probably does not increase the number of pouch failures, at 
least in a group of selected patients. Pouchitis, occurring in approximately 
30% of ulcerative colitis patients, is the most frequent late complication and 
may lead to pouch excision. 
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3.1 Abstract 
The immediate postoperative and long-term functional results of 51 ulcera-
tive colitis patients and 21 familial adenomatous polyposis patients who 
underwent ileal J-pouch anal-anastomosis (IPAA) were compared in this 
42 study. The incidence of postoperative complications requiring reoperation 
was not statistically different in both groups. The mean daily stool frequency 
was significantly higher in colitis patients. Pouchitis occurred in 44% of coli-
tis patients but not in polyposis patients (p < 0.005). Symptoms of pouchitis 
included bloody diarrhea, urgency, abdominal pain, weight loss, fever and 
arthritis. Six colitis patients required pouch excision because of intractable 
pouchitis. The overall pouch excision rate was 22% in ulcerative colitis 
patients and 5% in familial adenomatous polyposis patients (p = 0.16). 
Patient satisfaction was good in 46% of ulcerative colitis patients and 76% of 
polyposis patients (p < 0.05). Our data demonstrate that the long-term out-
come of IPAA is more favourable in polyposis patients than in colitis patients. 
Pouchitis is a major long-term complication occurring exclusively in colitis 
patients. 
3.2 Introduction 
Total colectomy and ileal pouch-anal anastomosis (IPAA) is an attractive sur-
gical alternative for colectomy and permanent ileostomy in patients with 
chronic ulcerative colitis and familial adenomatous polyposis because the 
entire colonic mucosa is removed while anal function can be preserved and 
the necessity for permanent ileostomy is eliminated (1,2). Long-term func-
tional results are generally gratifying as defecation frequency and degree of 
incontinence is acceptable in most patients. Pouchitis however, a nonspecific 
inflammation of the ileal reservoir, is a major long-term complication occur-
ring in 8-44% of patients (3-15). Symptoms of pouchitis include bloody diar-
rhea, urgency of defecation associated with abdominal cramps, malaise, and 
occasionally fever and arthritis. Little is known about the pathogenesis of 
pouchitis. It has been suggested that pouchitis is the result of bacterial over-
growth in the ileal pouch (4-6). The generally satisfactory response to treat-
ment with metronidazole supports this hypothesis. Bacterial overgrowth 
however, is probably not the sole etiological factor because pouchitis occurs 
less frequendy in familial adenomatous polyposis patients than in ulcerative 
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colitis patients (4-6). Therefore several authors have suggested that pouchitis 
is a novel manifestation of inflammatory bowel disease persisting after total 
colectomy with IPAA (5,16-21). 
It is still a matter of debate whether to perform subtotal colectomy with 
ileorectal anastomosis or total colectomy with IPAA in patients with familial 
adenomatous polyposis. The risk of cancer in the rectal stump after ileorectal 43 
anastomosis is approximately 10 percent and makes indefinite proctoscopic 
screening necessary (22). Still many surgeons prefer ileorectal anastomosis 
in familial adenomatous polyposis arguing that it is less prone to complica-
tions and provides better long term results. These arguments are usually 
based on results achieved in series of IPAA performed in ulcerative colitis 
patients. However, results of the procedure are probably better in polyposis 
than in colitis because polyposis patients are usually younger and in a better 
physical condition at the time of proctocolectomy than colitis patients. More-
over, polyposis patients are less prone to pouchitis. The aim of this study was 
to compare the immediate postoperative and long term results of IPAA in 
patients with ulcerative colitis and familial adenomatous polyposis and to 
evaluate the occurrence, symptoms, and outcome of pouchitis. 
3.3 Patients and methods 
3.3.I PATIENTS 
Between July 1983 and May 1990, 72 patients underwent IPAA for either ulce-
rative colitis (51 patients) or familial adenomatous polyposis (21 patients) at 
the Nijmegen University Hospital. Forty-four of the patients were male; 28 
were female. The mean age (SD) at the time of the ileal pouch procedure was 
34 (13) years (range 10-61 years) in the ulcerative colitis patients and 27 (11) 
years (range 10-55 years) in the polyposis patients (p < 0.05). Twenty-seven 
(38%) patients had undergone subtotal colectomy with ileorectal anastomo-
sis (4 colitis and 4 polyposis patients) or ileostomy (18 colitis patients and 
one polyposis patient) prior to the construction of the ileal pouch. In the 
remaining 45 patients the initial operation included abdominal colectomy, 
mucosal proctectomy, and endorectal IPAA. All ulcerative colitis patients 
except those who had undergone colectomy with ileostomy (33 patients) but 
none of the polyposis patients used corticosteroids at the time of the ileal 
pouch procedure. 
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3-3-2 SURGICAL PROCEDURE 
In all patients a 'J' reservoir was constructed. The pouch was created by fol-
ding the terminal ileum back on to itself and anastomosing the limbs side to 
side. The rectal mucosa was removed from the rectal stump down to the den-
tate line via a transanal approach. The ileal pouch was extended into the pel-
44 vis endorectally and its apex opened and sutured circumferentially to the den-
tate line. In all patients a temporary loop ileostomy was established. At a 
second operation the temporary ileostomy was closed and ileal continuity 
reestablished. The mean interval (SD) between construction of the IPAA and 
ileostomy closure was 6.1 ± 4.4 months in colitis patients and 4.4 ± 3.9 
months in polyposis patients (p < 0.01). 
3.3.3 ASSESSMENT OF RESULTS 
Immediate postoperative data included mortality and morbidity requiring 
reoperation within 30 days after IPAA and ileostomy closure. Follow-up data 
included stool frequency, degree of incontinence, use of loperamide, occur-
rence of pouchitis, social functioning, and patient satisfaction. The records 
of all patients were studied retrospectively in June 1991. Patients with incom-
plete follow-up data were contacted by telephone for answers to a follow-up 
questionnaire. Stool frequency per 24 hours and per night was an estimate by 
the patients of the average number of bowel movements and was recorded 1, 
3, 6,12 and 24 months after ileostomy closure. Incontinence was defined as 
involuntary loss of mucus or stool requiring a perineal pad. The presence of 
incontinence during the day and night and use of loperamide were recorded 
12 months after ileostomy closure. Pouchitis was defined as episodes with 
abdominal cramping, bloody diarrhea, increased stool frequency, urgency, 
malaise, and/or fever associated with endoscopic and histologic signs of 
acute inflammation. Endoscopic signs of inflammation included mucosal 
hyperaemia with loss of vascular pattern with or without ulceration. Histolo-
gical signs of acute inflammation were significant neutrophil infiltration and 
ulceration (18). Patients whose ileostomies were closed were asked whether 
they were able to work full-time or not and whether they preferred the pouch 
to the ileostomy. 
3.3.4 STATISTICAL ANALYSIS 
Proportions were analyzed by chi-square tests with Yates's modification 
when appropriate. Comparisons of continuous variables were made using 
Student's t test or, when appropriate, the rank-sum test. The risk of pouchitis 
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in the colitis and polyposis groups was estimated using the Kaplan-Meier life 
table analysis. The two actuarial curves were compared using the log-rank 
test. A p-value < 0.05 was considered statistically significant. 
3.4 Results 45 
3.4.I IMMEDIATE POSTOPERATIVE RESULTS 
One polyposis patient died of sepsis after the ileal pouch procedure and one 
colitis patient died of a cardiac arrhythmia after ileostomy closure. After the 
initial operation 13 (25%) ulcerative colitis patients and 2 (10%) polyposis 
patients required one or more laparotomies because of postoperative compli-
cations. After ileostomy closure 13 (30%) colitis patients and four (20%) poly-
posis patients needed reoperation (Table 3.1). These differences were not 
statistically significant. Small bowel obstruction was the most frequent com-
plication requiring relaparotomy after both the ileal pouch procedure and ile-
ostomy closure. 
Table 3.1 Postoperative complications requiring reoperation in ulcerative colitis 
(UC) and familial adenomatous polyposis (FAP) patients after the ileal pouch proce-
dure (IPAA) and after ileostomy closure. 
IPAA 
UC FAP 
(n=5i) (n=2i) 
Ileostomy closure 
UC FAP 
(n=43) (n=2o) 
small bowel 5(10%) 2(10%) 
obstruction 
anastomotic 6 (12%) 
dehiscence 
other 
total 
2(4%) 
13 (25%) 2 (10%) 
small bowel 4 (9%) 2 (10%) 
obstruction 
anastomotic 4 (9%) 
leakage 
rectovaginal 3 (7%) 
fistula 
other 2 (5%) 2 (10%) 
13 (30%) 4 (20%) 
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3 · 4 · 2 LONG TERM FUNCTIONAL RESULTS 
Analysis of stoolfrequency, use of loperamide, occurrence of pouchitis and 
incontinence was performed in all patients whose ileostomies were taken 
down. In four colitis patients the pouch was removed before ileostomy clo­
sure and in three colitis patients the ileostomy was still not closed at the time 
46 of evaluation. Mean follow-up after ileostomy closure in the remaining 43 
colitis and 20 polyposis patients was 34 months (range 2-92) and 63 months 
(range 6-90) respectively. Pouch excision rate was calculated in all colitis and 
polyposis patients. 
Stool jrequency — The mean stool frequency per 24 hr after ileostomy closure 
decreased gradually in both patient groups but was significantly lower in poly­
posis patients any time after ileostomy closure (Figure 3.1a). Nocturnal stool 
frequency was significantly lower in polyposis patients one month after ileo­
stomy closure and tended to be lower in these patients thereafter (Figure 3.1b). 
Atone year eight (26%) colitis patients and one (5%) polyposis patient had 
more than eight stools per 24 hr. At that time five (16%) colitis patients and 
one (5%) polyposis patient had more than two stools during the nighttime. 
Pouchitis — The overall incidence of pouchitis during follow-up was 44% in 
ulcerative colitis patients (rg out of 43 patients) and 0% in polyposis patients 
(p < 0.005). The presence of pouchitis was confirmed by endoscopic and his­
tological examination in all patients with symptoms compatible with pouchi­
tis. Life table analysis of risk of pouchitis for both ulcerative colitis and fami­
lial adenomatous polyposis is shown in Figure 3.2. The probability of pouchi­
tis occurring within five years after ileostomy closure in colitis patients was 
57% versus 0% in polyposis patients (p < 0.001). The mean time to the first 
pouchitis episode was 14 months (range, 1-48 months). 
The incidence of pouchitis was not affected by sex or age. The occurrence 
of pouchitis did not affect the incidence of incontinence. The mean number 
of stools per 24 hr during episodes of pouchitis increased significantly ( j.y 
vs 13.5 stools/day, ρ < o.ooi). The stool frequency in patients with pouchitis 
before the first pouchitis episode was similar to that in ulcerative colitis 
patients who never developed pouchitis. 
Pouchitis occurred in 8 (36%) of the 22 colitis patients who had undergone 
subtotal colectomy prior to the ileal pouch procedure and in 11 (38%) of 29 
colitis patients in whom IPAAwas the initial procedure (NS). 
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months after Ileostomy closure 
Figure 3.1 Twenty-four hr (a) 
and nocturnal (b) stool fre­
quency (mean + SEM) 1,3,6,12 
and 24 months after ileostomy 
closure in ulcerative colitis 
patients (closed bars) and 
familial polyposis patients 
(hatched bars) (* ρ < 0.05). 
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Figure 3.2 Life 
table analysis of 
risk of pouchitis 
after ileostomy 
closure in ulcera-
tive colitis 
patients and 
familial polypo-
sis patients. 
Pouchitis did not 
occur in polypo-
sis patients. The 
risk of pouchitis 
was significantly 
higher in ulcera-
tive colitis 
patients. 
Initial episodes of pouchitis were treated with metronidazole in all 
patients. When this treatment was unsuccessful, local or oral corticosteroids 
were prescribed (13 patients). Recurrent episodes were treated similary. 
Twelve (63%) of the 19 patients with pouchitis responded favourably to medi-
cal treatment. Pouchitis occurred only once in two patients (11%). Ten (53%) 
patients had recurrent pouchitis. The remaining 7 (37%) patients developed 
chronic pouchitis that responded poorly to medical treatment. In 6 (32%) 
patients from the latter group the pouch was removed because of intractable 
pouchitis. In the seventh patient the pouch was still not removed at the time 
of evaluation. Histological examination of the removed pouches showed no 
signs of Crohn's disease. 
Symptoms of pouchitis included bloody diarrhea, urgency, increased stool 
frequency, abdominal cramps, fatigue, fever, and weight loss (Table 3.2). 
Five patients with pouchitis (26%) developed arthritis. Arthritis occurred 
concomitantly with the onset of pouchitis episodes and affected knees, ank-
les, elbows, and wrists. Three of these patients required permanent ileosto-
my because of intractable pouchitis. In all arthritis disappeared rapidly after 
pouch excision. Arthritis did not occur in patients without pouchitis. The 
remaining two patients who developed arthritis responded favourably to oral 
corticosteroids. 
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Endoscopy showed inflammation (hyperaemia, oedema, loss of vascular pat-
tern) of the ileal pouch mucosa in all pouchitis patients. Ulceration was seen 
in 16 (84%) patients. Mucosal biopsies from the ileal reservoir showed acute 
(infiltration of polymorphonuclear cells) and chronic inflammation (total or 
partial of villous atrophy and infiltration of lymphocytes, plasma cells, and 
eosinophils) in all patients with pouchitis. 49 
Table 3.2 Symptoms of pouchitis (n=i g) 
symptom number of patients (%) 
increased stool frequency 13 (68) 
abdominal pain 14 (74) 
bloody stools 15 (79) 
fever 8 (42) 
weight loss 8 (42) 
fatigue 15 (79) 
arthritis 5 (26) 
Incontinence — One year after ileostomy closure one ulcerative colitis patient 
and one polyposis patient were incontinent during daytime. During night-
time 16 (43%) colitis patients and 6 (32%) polyposis patients required a pad 
because of incontinence (NS). 
Use of loperamide — One year after ileostomy closure 19 (51%) ulcerative colitis 
patients and 12 (63%) polyposis patients used loperamide in order to decrea-
se stool frequency (NS). 
Pouch excision — There was a tendency towards a lower rate of pouch excision 
in polyposis patients but this failed to achieve statistical significance. In 11 
(22%) of the 51 ulcerative colitis patients and in one (5%) of the 21 polyposis 
patients, the pouch was removed and a permanent ileostomy constructed 
(p=o.i6). Reasons for pouch excision were anastomotic dehiscence in three 
ulcerative colitis patients, pelvic abscesses in one colitis patient, intractable 
pouchitis in six colitis patients, incontinence in one colitis patient, and unac-
ceptable high stool frequency in one polyposis patient. The probability of 
pouch excision (Figure 3.3) occurring within five years after the ileal pouch 
procedure was 26% in ulcerative colitis patients versus 6% in polyposis 
patients (p=o.07). 
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anastomosis. 
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rate of pouch 
excision in poly­
posis patients 
but this failed to 
achieve statisti­
cal significance. 
Ten (45%) out of 22 ulcerative colitis patients and one (20%) out of 5 poly­
posis patients who had undergone subtotal colectomy prior to the ileal pouch 
procedure required pouch excision. This difference was not statistically 
significant. When all patients with prior subtotal colectomy (n=27) were con­
sidered as a group and compared to the patients in which proctocolectomy 
with IPAA was the initial procedure (n=45) the number of excised pouches 
was 11 (41%) and 1 (2%) respectively (p < 0.001). 
Final outcome — In three ulcerative colitis patients the ileostomy was still not 
closed at the time of evaluation. These patients were not included in the eva­
luation of final outcome. In the ulcerative colitis group the operation was 
unsuccessful in 12 patients (one postoperative death, 11 pouch excisions). 
The remaining 36 patients all preferred their pouch to the ileostomy. Howe­
ver, 14 of these patients (including 7 patients with pouchitis) felt unable to 
work full-time because of fatigue. Therefore, at the long-term the procedure 
was entirely successful in only 22 ulcerative colitis patients (46%). In the 
polyposis group the procedure failed in two patients (one postoperative 
death, one pouch excision). The remaining 19 patients all preferred the 
pouch to the ileostomy. Two of these patients were unable to work full-time 
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because of fatigue. Finally, 16 (76%) polyposis patients felt very satisfied with 
their pouch. The difference between the two groups was statistically signifi-
cant (p< 0.05). 
3.5 Discussion 51 
In this study the immediate postoperative and long-term functional results of 
IPAA in 51 ulcerative colitis patients and 21 familial adenomatous polyposis 
patients were compared. The interval between the ileal pouch procedure and 
ileostomy closure was longer in colitis patients than in polyposis patients. 
Ileostomy closure was carried out at the time that the patients were recovered 
from the ileal pouch procedure. Precise data demonstrating that polyposis 
patients are in better health at the time of the ileal pouch procedure than coli-
tis patients are lacking in this retrospective study. Nevertheless, polyposis 
patients are usually operated electively whereas colitis patients undergo 
(procto)colectomy when severe and disabling disease is not responding to 
medical treatment. The majority of colitis patients but none of the polyposis 
patients used corticosteroids at that time. Postoperative complications requi-
ring relaparotomy after both the ileal pouch procedure and ileostomy closure 
occurred more frequently in ulcerative colitis patients, but these differences 
did not reach statistical significance. 
The major long-term complication after IPAA was pouchitis, which occur-
red in 44% of colitis patients but not in polyposis patients. The estimated risk 
of pouchitis five years after ileostomy closure in colitis patients was 57%. As 
duration of follow-up in ileal pouch patients increases, the incidence of 
pouchitis also tends to increase (5). Even after three years of follow-up some 
new cases of pouchitis arose in our series. 
The incidence of pouchitis was higher compared to many other reports (3-
15), where the incidence ranges from 8% to 44%. This wide range probably 
reflects the lack of a uniform diagnostic standard. Moskowitz et al. (18) sug-
gested that for an unequivocal diagnosis symptoms of pouchitis should be 
accompanied by endoscopic and histological features of acute inflammation. 
In our study all patients with clinical pouchitis fulfilled these criteria. 
In some reports (9,10,15) colitis patients and polyposis patients were con-
sidered as one group. When colitis patients would have been considered as a 
separate group the rate of pouchitis in these patients would probably have 
been higher. Nevertheless, the rate of pouchitis in our colitis patients is hig-
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her than in the colitis patients in the Mayo Clinic series (31%) (5). It is difficult 
to explain this discrepancy. In our series pouchitis was carefully looked for by 
endoscopy and histology, whereas in the Mayo Clinic series pouchitis was 
merely a clinical diagnosis. 
The cause of pouchitis remains unclear. Bacterial overgrowth due to fecal 
52 stasis in the ileal pouch has been suggested as a possible pathogenic factor. 
In a study by Go et al. (23) ileum effluents of Kock's continent ileostomy 
patients showed significantly higher counts of anaerobic microorganisms 
(eg, Bacteroides) than in ileum effluents of patients with a conventional ileo-
stomy. Nasmyth et al. (17) also found higher numbers of Bacteroides in ileoan-
al pouch effluents compared with conventional ileostomy effluents. Howe-
ver, quantitative cultures of pouch effluents from patients with pouchitis did 
not reveal higher numbers of anaerobes compared with controls without evi-
dence of pouchitis (24). These findings were confirmed by Luukkonen et al. 
(25) who found significantly higher anaerobic counts in pouch patients com-
pared to conventional ileostomy patients, but no specific changes in fecal 
bacteriology were found in patients with pouchitis. However, since many 
patients respond to metronidazole, anaerobic bacterial overgrowth may con-
tribute to the pathogenesis of pouchitis. 
Several authors have suggested that pouchitis is a novel manifestation of 
inflammatory bowel disease after proctocolectomy (5,16-21). In most studies 
pouchitis occurred exclusively in ulcerative colitis patients. Only a few cases 
of pouchitis in polyposis patients have been reported by workers from the 
Mayo Clinic (4,5). These cases were poorly documented because endoscopy 
was not performed in these patients. In the Mayo Clinic population ulcerative 
colitis patients were at much higher risk of pouchitis compared to polyposis 
patients. Moreover, ulcerative colitis patients with extraintestinal manifesta-
tions of inflammatory bowel disease before proctocolectomy were at higher 
risk of pouchitis compared to those without extraintestinal manifestations. 
In agreement with our experience, in some patients from the Mayo Clinic a 
temporal relationship between flares of extraintestinal manifestations and 
pouchitis was observed (5). These findings support the hypothesis that 
pouchitis is a novel manifestation of inflammatory bowel disease. 
It has been suggested that the pouch mucosa, in an adaptive response to its 
new luminal environment, undergoes colonic metaplasia and thus may beco-
me vulnerable to immune damage in predisposed people (16,19,26-29). In a 
study on mucosal characteristics of pelvic ileal pouches using routine histolo-
gy, mucin histochemistry, and monoclonal antibodies directed towards colo-
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nie and small bowel specific proteins (29), villous atrophy and colonic type 
sulphomucin was found in all pouchitis patients. However, sucrase-isomal-
tase, a small bowel specific disaccharidase, was present in all pouches irre-
spective of the presence of villous atrophy or pouchitis. It was concluded that 
although some ileal pouches, especially those with signs of acute inflamma-
tion, acquire certain colonic characteristics, complete colonic metaplasia 53 
does not occur. 
Another factor that has been suggested to play a pathogenic role in pouchi-
tis is bacterial deconjugation and dehydroxylation of primary bile acids 
(16,30). Under normal circumstances the greatest part of the conjugated bile 
acid pool is transported actively by the ileal mucosa into the portal venous 
system. Less than ten percent of the bile acid pool passes the cecal valve and is 
deconjugated by the colonic bacterial flora. After deconjugation the unconju-
gated primary bile acids are dehydroxylated by the colonic bacteria to secon-
dary bile acids. Loss of hydroxyl groups makes bile acids more lipophilic than 
the corresponding primary bile acids (31). Under experimental conditions 
secondary bile acids like deoxycholic acid cause an increase of water and salt 
permeability in colonic mucosal cells followed by cell death (32). Stasis and 
bacterial overgrowth in the ileal pouch may lead to deconjugation and dehy-
droxylation of bile acids. These secondary bile acids may exert a toxic effect 
on the ileal pouch mucosa. This mechanism plays at best a supplementary 
role in the pathogenesis of pouchitis because it does not explain why pouchi-
tis does not occur in familial adenomatous polyposis. 
Patients who had undergone subtotal colectomy prior to the ileal pouch 
procedure were at high risk of pouch excision. The incidence of pouchitis 
was similar in the colitis patients who had undergone subtotal colectomy 
prior to the ileal pouch procedure compared to those in whom the pouch pro-
cedure was the initial operation. This suggests that subtotal colectomy prior 
to IPAA is a risk factor for pouch excision. In three patients the pouch was 
removed because of complete anastomotic dehiscence and in one patient 
because of pelvic abscesses, probably because of incomplete dehiscence. 
Traction on the pouch-anal anastomosis is probably higher in patients who 
have undergone previous intestinal surgery due to adhesions and mesenterial 
retraction. 
In conclusion, the rate of complications requiring relaparotomy after both 
IPAA and ileostomy closure is considerable both in ulcerative colitis and 
familial polyposis patients. Long-term functional results are better in familial 
adenomatous polyposis compared to ulcerative colitis since pouchitis does 
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not occur in polyposis patients. Moreover, the stool frequency is lower in 
polyposis patients and patient satisfaction is better in these patients. Pouchi-
tis is the major long-term complication of IPAA occurring in approximately 
40% of ulcerative colitis patients but not in polyposis patients. Pouchitis may 
lead to pouch excision in a considerable number of patients. Many pouchitis 
54 patients show a favourable response to metronidazole, although this respon-
se is usually temporary. Patients who have undergone subtotal colectomy 
prior to the ileal pouch procedure are at higher risk of pouch excision. These 
results have important implications for the information that should be given 
to patients who are candidates for IPAA. 
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4·ΐ Abstract 
A decreased ileal absorption of bile acids in elderly subjects may lead to an 
increased exposure of the colonic mucosa to secondary bile acids. This may 
contribute to an enhanced risk of colorectal cancer. In this study fasting and 
58 postprandial conjugated and unconjugated serum levels of cholic, cheno-
deoxycholic, and deoxycholic acid in 12 elderly and 12 younger subjects were 
investigated. Intestinal transit time, gallbladder emptying and jejunal bacte­
rial flora were also studied in both age groups. Fasting levels of conjugated 
and unconjugated serum bile acids were similar in both age groups. 
Postprandial levels of all individual conjugated bile acids increased to a 
significantly higher extent in the younger subjects. Postprandial unconjuga­
ted serum bile acid levels did not differ significantly between both age groups, 
although unconjugated deoxycholic levels tended to increase to higher levels 
in the elderly. Results of jejunal bacterial counts, gallbladder emptying and 
intestinal transit time were similar in both groups. These data suggest that 
conjugated bile acids are reabsorbed less effectively in elderly subjects. 
4.2 Introduction 
Colorectal cancer is a disease of elderly subjects. It has been suggested that a 
decreased ileal absorption of bile acids in elderly subjects may lead to an 
increased exposure of the colonic mucosa to secondary bile acids (1). This 
may contribute to an enhanced risk of colorectal cancer since secondary bile 
acids are thought to have co-carcinogenic effects on the colonic mucosa (2-4). 
The primary bile acids cholic (CA) and chenodeoxycholic acid (CDCA), that 
escape to the enterohepatic circulation are deconjugated and converted in the 
large bowel into their secondary bile acids deoxycholic (DCA) and lithocholic 
acid respectively. It has been demonstrated that the conversion of CA into 
DCA is increased in elderly subjects compared to younger subjects (1). 
In order to find further evidence that ageing influences bile acid reabsorp­
tion in the small intestine we studied fasting and postprandial conjugated 
and unconjugated serum levels of CA, CDCA, and DCA in twelve young adults 
and twelve elderly subjects. To our knowledge this is the first time that 
postprandial serum levels of individual bile acids have been studied in 
different age groups. 
To investigate whether impaired intestinal motility and small intestinal 
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bacterial overgrowth in the elderly may be responsible for age dependent 
differences in bile acid metabolism, intestinal transit time, gallbladder 
emptying, and jejunal bacterial flora were also studied in both age groups. 
Since elevated unconjugated serum bile acid levels are a useful marker for 
small intestinal bacterial overgrowth (5-9) both conjugated and unconjuga­
ted serum bile acid levels were studied in both age groups. 59 
4.3 Subjects and methods 
Subjects — Twenty-four healthy subjects were studied; 12 were younger than 
60 years (mean age 37 years, range 22-59 years; 7 female, 5 male) and 12 were 
older than 60 years (mean age 67 years, range 60-82 years; 7 female, 5 male). 
None of the subjects had abdominal symptoms, a history of gastrointestinal 
disease or abdominal surgery. Routine liver function tests were normal in all 
subjects. Informed consent was obtained from each subject and the protocol 
had been approved by the Ethics Committee of the University Hospital 
Nijmegen. 
Experimental protocol— The subjects were studied after an overnight fast. 
Venous blood samples for analysis of serum bile acid levels were obtained 
before and at 30, 60, 90,120,150,180, 210, and 240 minutes after consump­
tion of a standardized breakfast. The breakfast consisted of one slice of 
bread, 5 g of margarine, 20 g of cheese, one boiled egg, 150 ml of yogurt and 
one cup of tea containing 5 g of sugar (21 g of protein, 21.5 g of fat, 34 g of 
carbohydrate, 413 kcal) and was ingested within 15 minutes. At time о minu­
tes 12 g of lactulose (Legendal"-· Zambón, The Netherlands) in 100 ml water 
was ingested. 
Analysis of serum bile acids—Venous blood samples were allowed to clot. After 
centrifugation the separated serum was frozen at -20°C for subsequent analy-
sis. Serum levels of the conjugated and unconjugated fractions of CA, CDCA 
and DCA were measured by capillary gas-liquid chromatography, a highly 
accurate and sensitive method (10). 7cx,i2a-dihydroxy-5-ßcholanoic acid 
(Steraloids, Wilton, NH, USA) was added as an internal standard. Bile acids 
were extracted from serum using Ci8-bonded silica cartridges (SepPak, 
Waters Associates, Milford, MA, USA) (11). Separation of conjugated and 
unconjugated bile acids was carried out by means of column chromatography 
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using the lipophilic anion exchanger diethylaminohydroxypropyl Sephadex 
LH-20 (Lipidex-DEAP, Packard Instruments, Groningen, The Netherlands) 
(n). The conjugated fractions were subjected to enzymatic hydrolysis by cho-
lylglycine hydrolase (from Clostridium perfrimjens, Sigma, St. Louis, MO, USA). 
After enzymatic hydrolysis the deconjugated bile acids were extracted and 
60 eluted on Lipidex-iooo columns (10). The bile acids were converted to methyl 
esters by 2,2-dimethoxypropane (Merck, Darmstadt, Germany). After methy-
lation the trimethylsilyl ether dérivâtes were prepared by addition of a solu-
tion of pyridine, hexamethyldisilazane and trimethylchlorosilane (3:2:1 by 
vol.). Immediately before application to the gas Chromatograph the silylation 
reagent was dried under nitrogen and the samples were redissolved in 50 μι 
hexane. Two μι of this solution was used for injection. Separation and quan­
tification of individual bile acids was performed on a Packard 430 gas-liquid 
Chromatograph (Packard Instruments, Delft, The Netherlands) with a flame 
ionisation detector and equipped with a 25 m* 0.22 mm glass capillary 
column (CP-SiI-5 CB, Chrompack, Middelburg, The Netherlands). The Chro­
matograph was equipped with an automatic solid injection system. Helium 
was used as carrier gas. The injection temperature was 285°C and the indivi­
dual bile acids were separated by computer based stepwise increment of 
column temperature from i50-2go°C. The flame ionisation temperature was 
28o°C. Bile acids were identified by comparing the retention times of the 
individual bile acids to those of reference bile acids. 
Bacterial examination ojjejunal Jluid — Jejunal fluid was obtained under anaero­
bic conditions after an overnight fast by means of a radio-opaque Polyvinyl­
chloride tube. The samples were collected at least 15 cm beyond the duodeno­
jejunal junction. The position of the tube was checked fluoroscopically. To 
prevent contamination with saliva the tip of the tube was sealed with an agar 
plug. Before sampling the agar plug was expelled by inflating nitrogen 
through the tube. Immediately after sampling 0.5 ml of jejunal fluid was 
added to 4.5 ml of a solution containing 1.0 g glucose, 4.0 g starch, 10.0 g 
tryptose, 5.ogNaCl, 3.ogK2HP04,0.5 gKHiPC^o.s gMgSC4o.5 gcysteine-
HC1 and 3.0 gyeast extract dissolved in 1000 ml H2O. The procedure was con­
tinued under anaerobic conditions with an oxygen tension of less than 5 
p.p.m. (12). After homogenization, serial dilutions of the homogenate were 
spread on a non-selective medium containing 22.5 g agar with 7% blood 
obtained from sheep. Anaerobic cultures and aerobic cultures were 
continued for eight and three days respectively at 37°C. For aerobic culture, 
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three selective media were used in addition to the above mentioned non-
selective medium. Direct microscopic counting of bacteria was done using 
the method described by Holdeman (13). 
Gallbladder emptying — In a subgroup of five younger and five elderly subjects 
gallbladder volumes were measured by real-time ultrasonography. 61 
Gallbladder volumes were calculated by the sum of cylinders method using a 
computerized system (14,15). Two longitudinal and two transverse images of 
the gallbladder were obtained at o, 15, 30, 45, 60, 75, 90, 105, 120,150 and 
180 minutes. The mean of two measurements was used for further analysis. 
Small intestinal transit time — Small intestinal transit time was measured by the 
lactulose H2 breath test. The hydrogen concentration in expired air was 
measured according to the method described by Dolmans et al. (16). End 
expiratory breath samples were collected under basal conditions and every 15 
minutes thereafter. The time between ingestion of lactulose until a sustained 
rise in breath hydrogen concentration of at least 15 parts per million (ppm) 
was defined as small intestinal transit time. 
Total intestinal transit time — Total intestinal transit time was measured by the 
single stool method using radio-opaque markers according to Cummings 
and Wiggins (17). 
Statistical analysis — Results were expressed as the mean ± SEM unless stated 
otherwise. Bile acid curves were tested by standard repeated measurements 
analysis of variance. To eliminate skewness of the bile acid distribution a 
logarithmic transformation of the data was applied for statistical testing. 
Firstly, time effects were studied. Secondly, the hypothesis that time effects 
were equal for both groups was tested. When time effects were equal the 
mean bile acid curves were considered to be parallel. When the bile acid cur-
ves were non-parallel time effects were described separately for both groups. 
The correlation between age and the sum of individual integrated serum bile 
acid levels of the three major conjugated bile acids (CA + CDCA + DCA) was 
calculated using Pearson's correlation coefficient. Intestinal transit times and 
gallbladder volumes were compared with the one-tailed Student's t-test. Inte-
grated bile acid values and jejunal bacterial counts were compared with the 
one-tailed Student's t-test after logarithmic transformation to eliminate 
skewness in the distribution. One-tailed tests were used since the hypothesis 
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Figure 4.1 Fasting and postprandial con-
jugated serum levels (mean ± SEM) of 
cholic (CA).chenodeoxycholic (CDCA) 
and deoxycholic acid (DCA) in the youn-
ger subjects (closed markers) and the 
elderly subjects (open markers). All bile 
acid curves of both age groups were non-
parallel (CA: p<o.ooi, CDCA: p<o.oi; 
DCA p<o.ooi; repeated measurements 
analysis). 
120 180 240 
Time (min) 
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was aimed at one-directional changes: a slower transit time, slower gallblad-
der emptying and more bacterial overgrowth at older age. A p-value <o.05 
was considered statistically significant. 
4.4 Results 63 
Conjugated bile acids — Fasting conjugated serum bile acid levels were not 
significandy different between both age groups. Postprandially, the conjuga-
ted bile acid levels increased rapidly in all subjects (p<o.ooi). The levels of all 
individual conjugated bile acids increased to a higher extent in the younger 
subjects compared to the elderly subjects. Repeated measurements analysis 
revealed that the curves of all conjugated bile acids were non-parallel in both 
age groups (Figure 4.1). The peak levels were reached within two hours and 
tended to occur slightly later in the elderly subjects but no significant 
differences between the two age groups were observed. After the peak, the 
conjugated bile acid levels decreased gradually and levelled off to 
approximately twice baseline values four hours after the meal. Postprandial 
levels of CDCA were approximately twice as high as CA and DCA levels in 
both groups. 
The integrated conjugated bile acid values of both age groups are shown in 
Table 4.1. Integrated CA and CDCA levels were significandy higher in the 
younger subjects. The integrated DCA levels were similar in both age groups. 
Figure 4.2 shows the correlation between age and the sum of the individu-
al integrated conjugated bile acids levels (CA + CDCA + DCA). A significant 
negative correlation was found (r=-o.56; p<o.oi) between both parameters. 
Unconjugated bile acids — Fasting unconjugated serum bile acid levels were not 
significandy different in both age groups. Repeated measurements analysis 
revealed significant time trends of unconjugated CDCA (p<o.oi) and DCA 
(p<o.ooi) but not CA. However, these trends were not significantly different 
between both age groups. Levels of CDCA and DCA reached a maximum at 90 
and 120 minutes respectively. No differences between the time to peak con-
centration in the younger and elderly subjects were observed (Figure 4.3). 
After the peak a slow decrease was observed to approximately baseline levels, 
four hours after the meal. 
The integrated unconjugated serum bile acid values are shown in Table 
4.2. No significant differences between the two age groups were observed. 
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Table 4-1 Integrated conjugated serum bile acid levels (CA=cholic, CDCA=cheno-
deoxycholic DCA=deoxycholic acid in pM.min; mean ± SEM) in the younger and 
elderly subjects. 
CA 
CDCA 
DCA 
young 
304141 
662 ± 67 
269 ± 30 
old 
185 ±26 
500 + 64 
232131 
p-value 
p<o.05 
p=o.o5 
NS 
2500 
2000 
1500 
1000 
500 
integrated conjugated 
• 
• 
• 
• 
• 
• 
• · ^^"* 
bile acids 
I--0.56 
p<0.01 
• · 
• · 
• · 
• 
• 
20 30 40 50 60 70 80 
age (yr) 
Figure 4.2 Correlation 
between age and the sum of 
the individual integrated valu-
es of conjugated CA, CDCA, 
and DCA. 
Table 4.2 Integrated unconjugated serum bile acid levels (pM.min; mean ± SEM) in 
the younger and elderly subjects. 
young 
CA 
CDCA 
DCA 
66 ± 9 
87 ±12 
98 + 21 
old 
64 ±11 
93 ±17 
122 ± 2 0 
p-value 
NS 
NS 
NS 
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Figure 4.3 Fasting and postprandial 
unconjugated serum levels (mean + 
SEM) of cholic (CA),chenodeoxycholic 
(CDCA) and deoxycholic acid (DCA) in 
the younger subjects (closed markers) 
and the elderly subjects (open markers). 
Time trends were significant for CDCA 
(p<o.oi) and DCA (p<o.ooi), but not for 
CA. None of the bile acids curves showed 
significant differences between both 
groups. 
Ratio of unconjugated and conjugated serum bile acids—The ratio of the integrated 
unconjugated and conjugated serum bile acid levels are shown in Table 4.3. 
The ratio of unconjugated and conjugated DCA levels tended to be higher in 
the elderly subjects (p=o.o7). The ratios of the unconjugated and conjugated 
primary bile acids were not significantly different between both age groups. 
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Table 4.3 Ratio of integrated unconjugated and conjugated serum bile acid levels 
(mean ± SEM) in the younger and elderly subjects. 
CA 
CDCA 
DCA 
young 
0.24 + 0.04 
0.14 ±0.02 
0.34 ± 0.04 
old 
0.45 ± 0.12 
0.24 ± 0.07 
0.5810.10 
p-value 
NS 
NS 
p=o.07 
gallbladder volume (ml) 
0 30 BO 90 120 150 1Θ0 
Time (min) 
Figure 4.4 Postprandial gal­
lbladder emptying in five youn­
ger (closed markers) and five 
elderly subjects (open mar­
kers). No significant differen­
ces between both age groups 
were observed. 
Bacterial examination of jejunal Jluid — The sum of jejunal aerobic and anaero­
bic bacteria in the elderly subjects (median and range: io+·6, ιο2·4-ιο6·7 per 
ml) was not significantly different from that in the younger subjects (юЗ-9, 
io2-4-io6,>permI). 
Gallbladder emptying — No significant difference was found between fasting 
gallbladder volumes in the younger (22 + 1 ml) and elderly subjects (20 ± 3 
ml). The meal induced significant decreases in gallbladder volume in both 
age groups without statistically significant differences in the rate and extent 
of gallbladder emptying between the groups (Figure 4.4). 
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Small intestinal transit time — The mean small intestinal transit time as mea-
sured by the lactulose H2 breath test was 142 ±11 minutes in the younger sub-
jects and 135 ± 16 minutes in the elderly subjects. The difference between the 
two age groups was not statistically significant. 
Total intestinal transit rime — The mean total intestinal transit time was 45 ± 6 67 
hours in the younger subjects and 49 + 4 hours in the elderly subjects. The 
difference between the two age groups was not statistically significant. 
4.5 Discussion 
Conjugated serum bile acid levels are well known to increase rapidly after 
meals in healthy subjects (18-22). However, the influence of age on postpran-
dial bile acid levels has not been studied so far. In the present study fasting 
and postprandial conjugated and unconjugated serum levels of individual 
bile acids were compared in elderly and younger healthy subjects. All major 
conjugated bile acid levels increased to a higher extent postprandial^ in the 
younger subjects compared to the elderly subjects. We found a significant 
negative correlation between age and integrated postprandial conjugated 
serum bile acid levels. Since the fraction of bile acids in the portal blood 
cleared by the liver remains relatively constant and is independent of the load 
delivered to the liver (23,24) systemic bile acid levels are thought to be pro-
portional to the load of bile acids absorbed from the intestine. Therefore, the 
observed differences in this study between both age groups suggest that the 
postprandial conjugated bile acid load in the portal blood is smaller in elderly 
subjects. Several mechanisms may account for a smaller conjugated bile acid 
load in portal blood in elderly subjects. Firstly, the active ileal reabsorption of 
conjugated bile acids may be less effective in elderly subjects. Secondly, the 
amount of bile acids delivered to the duodenum after gallbladder emptying 
may be smaller in elderly subjects as a result of impaired gallbladder emp-
tying or a decreased secretion of bile acids by the liver. Finally, small intesti-
nal bacterial overgrowth in elderly subjects may lead to deconjugation of bile 
acids in the small intestine. The observed differences in the present study 
between both age groups however, cannot be explained by delayed gallblad-
der emptying or impaired intestinal motility in elderly subjects since gallblad-
der emptying and small intestinal transit time were similar in both age 
groups. Moreover, we found no evidence for small intestinal bacterial over-
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growth in the elderly age group since jejunal bacterial counts and unconjuga­
ted serum bile acid levels were similar in both age groups. 
Using a double isotope dilution method van der Werfet al. (ι) studied age 
dependent differences in bile acid metabolism and 7a-dehydroxylation. Ele­
ven young adults and n elderly subjects were studied. They found a higher 
68 input rate of DCA from the large bowel into the enterohepatic circulation in 
elderly subjects compared to younger subjects. The poolsize and synthesis 
rate of CA were similar in both age groups, whereas the poolsize of DCA was 
higher in the elderly. Since CA is transformed into DCA by the colonic flora 
these findings suggest that the active ileal absorption of conjugated bile acids 
is decreased in elderly subjects. The lower postprandial conjugated serum 
bile acid levels in our study give support to this hypothesis. Moreover, 
postprandial unconjugated levels of DCA and the ratio of integrated unconju­
gated and conjugated DCA levels tended to be higher in the elderly subjects. 
This suggests that the load of CA exposed to the colonic flora is increased in 
this age group. 
Previously, we have shown that the fecal secondary bile acid concentration 
is higher in elderly subjects compared to young adults (25). The concentra­
tion of fecal primary bile acids was similar in all age groups. Although it was 
suggested that the observed discrepancy was related to a lower dietary fibre 
intake in the elderly subjects, the higher fecal secondary bile acid concentra­
tion may well be explained by a decreased reabsorption of conjugated bile 
acids in the small intestine. 
It must be stated however, that our findings do not prove that conjugated 
bile acids are reabsorbed less effectively in elderly subjects. A decreased 
excretion of bile acids by the liver in elderly subjects may be another explana­
tion for the observed differences between in both age groups. Bile acid syn­
thesis rate, duodenal excretion of bile acids, and bile acid pool sizes were not 
measured in the present study. Age dependent differences of bile acid synthe­
sis have been studied by some other groups. Einarsson et al. (26) found a 
significant negative correlation between age and total bile acid synthesis in a 
group of 18 healthy subjects. However, no significant correlation was found 
between age and bile acid secretion into the duodenum. In the study by van 
der Werfet al. (ι), no significant differences in pool size and synthesis rate of 
CA were observed. Similarly, Valdivieso et al. (27) found no significant reduc­
tion in CA pool size or synthesis in older women. Thus, former studies gave 
little evidence for a lower duodenal excretion of conjugated bile acids in the 
elderly. 
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By others it has been suggested that primary bile acids are displaced from the 
enterohepatic circulation by DCA in elderly subjects because slowing of colo-
nic transit increases DCA absorption (1,28,29). In t n e present study however, 
total intestinal transit times were similar in both age groups. 
Bacterial transformation of primary bile acids into secondary bile acids has 
been implicated in colonic carcinogenesis. In animal models it has been 69 
shown that secondary bile acids may have (co-)carcinogenic effects on colo-
nic mucosa (2-4). Since colorectal cancer is a disease of elderly subjects seve-
ral investigators have searched for age dependent alterations in bile acid met-
abolism. In the present study further evidence was found for a decreased 
active ileal absorption of conjugated bile acids with increased spill-over into 
the large bowel in elderly subjects. A higher exposure of secondary bile acids 
to the colonic mucosa may contribute to the increased risk of colorectal can-
cer in these subjects. 
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5·ΐ Abstract 
Unconjugated serum bile acid levels have been found to be elevated in 
patients with small intestinal bacterial overgrowth. In order to determine 
sensitivity and specificity of unconjugated serum bile acids as a marker for 
74 small intestinal bacterial overgrowth we studied individual and total uncon­
jugated serum bile acid levels in 24 healthy subjects, 11 patients with culture 
proven bacterial overgrowth, 19 patients with other malabsorptive states, 10 
patients with ileal resection, and in 11 patients who had undergone proctoco­
lectomy with ileal pouch-anal anastomosis. Bile acids were measured using 
capillary gas-liquid chromatography. Individual as well as total unconjugated 
serum bile acid levels were significantly elevated in patients with bacterial 
overgrowth compared to controls and the other groups. Total unconjugated 
serum bile acid levels were outside the normal range in 9 out of n patients 
with bacterial overgrowth (sensitivity 82%), but within the normal range in 
all patients with other malabsorptive states (specificity 100%). The positive 
and negative predictive values of elevated total unconjugated serum bile acid 
levels as a marker for small intestinal bacterial overgrowth were 100% and 
90% respectively. Individual unconjugated bile acids provided a poorer dis­
crimination between patients with bacterial overgrowth and the other 
groups. It is concluded that determination of total unconjugated serum bile 
acid levels is of clinical value in the evaluation of patients with suspected 
small intestinal bacterial overgrowth. The sensitivity and specificity of total 
unconjugated serum bile acid levels are superior to those of individual uncon­
jugated bile acid levels. 
5.2 Introduction 
Small intestinal bacterial overgrowth is characterized by the presence of diar­
rhoea, malabsorption, and weight loss (1). In patients with clinically 
significant bacterial overgrowth, the number of bacteria in the small intesti­
nal fluid usually exceeds io7 ml"1. Both anaerobic and aerobic bacteria may be 
found. The golden standard for the diagnosis of small intestinal bacterial 
overgrowth is a properly collected and appropriately cultured aspirate from 
the proximal small intestine. The specimen should be obtained under 
anaerobic conditions, serially diluted, and cultured on selective media under 
aerobic and anaerobic conditions. Intestinal culture requires intubation of 
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the small intestine and time-consuming microbiological analysis. Therefore, 
several non-invasive tests have been developed to demonstrate bacterial over­
growth, but none of them have proved entirely satisfactory. The glucose-H2 
breath test gives false negative results in the absence of H2 generating bacte­
ria (2,3). Moreover, the glucose-Нг may not adequately distinguish patients 
with bacterial overgrowth from those with other malabsorptive states, inclu- 75 
ding coeliac disease. The specificity of the ^C-glycocholate breath test (4,5) 
is poor since this test does not differentiate bacterial overgrowth from ileal 
damage or resection resulting in excessive breath ^СОг production due to 
bacterial deconjugation within the colon of the unabsorbed bile salt. Al­
though the sensitivity and specificity of the ^C-xylose breath test (6) have 
been reported to be excellent (2,7), the use of a radioisotope is a major 
drawback. 
Unconjugated serum bile acids levels have been found to be elevated in 
patients with small intestinal bacterial overgrowth (8-12). However, little is 
known about unconjugated serum bile acid levels in other malabsorptive or 
maldigestive states including coeliac disease and chronic pancreatitis with 
exocrine pancreatic insufficiency. In order to investigate whether unconjuga­
ted serum bile acids offer a good discrimination between these conditions, we 
measured fasting individual unconjugated serum bile acids in healthy con­
trols, patients with small intestinal bacterial overgrowth, patients with untre­
ated coeliac disease, and patients with chronic pancreatitis and exocrine 
insufficiency. Patients who had undergone ileal resection were included as a 
disease control group, since unconjugated serum bile acid levels may be ele­
vated in these patients as a result of spill-over of unabsorbed bile acids into 
the colon. A group of patients who had undergone proctocolectomy with ileal 
pouch-anal anastomosis was also included since stasis in the ileal pouch may 
theoretically lead to bacterial overgrowth and deconjugation of bile acids. 
Serum bile acids were measured using capillary gas-liquid chromatography, a 
highly sensitive and accurate method for individual serum bile acid analysis. 
5.3 Subjects and methods 
5.3.I SUBJECTS 
Healthy subjects — Twenty-four healthy volunteers participated in this studied 
(mean age 52 years, range 22-82 years; 10 male, 14 female). None of these 
subjects had a history of abdominal surgery or gastrointestinal disease. 
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Stools were collected during 48 hours for analysis of fat excretion. None of 
the healthy subjects had steatorrhoea (fat excretion < 7 gram per day). In all 
healthy subjects results of a jejunal culture and a glucose H2 breath test were 
normal (<io? microorganisms per ml and an increase in EL-excretion <i5 
ppm in breath following oral administration of 100 g glucose, respectively). 
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Small intestinal bacterial ouerçjrotuth — Eleven patients (mean age 60 years, 
range 30-77 years; 8 male, 3 female) with culture proven small intestinal bac-
terial overgrowth participated in the study. The diagnosis of small intestinal 
bacterial overgrowth was established when a cultured jejunal aspirate 
demonstrated >ιο? microorganisms per ml in a patient with a gastrointesti­
nal disorder known to predispose to small intestinal bacterial overgrowth 
with signs of malabsorption (weight loss, anaemia, diarrhoea, reduced uri­
nary excretion of xylose, positive glucose H2 breath test, steatorrhoea). The 
causes of bacterial overgrowth, results of jejunal culture, and fecal analysis of 
fat excretion in the individual patients are shown in Table 5.1. 
Coeliacsprue—Eightpatients (meanage48years, range30-67years; 3 female, 
5 male) with untreated coeliac disease were studied. The diagnosis of coeliac 
disease was established in patients with malabsorption, a flat jejunal mucosa, 
and clinical improvement after withdrawal of gluten from the diet. 
Chronic pancreatitis — Eleven patients with chronic pancreatitis and steator­
rhoea (mean age 46 years, range 27-64 years; 7 male and 4 female) participa­
ted in the study. Pancreatic enzyme supplements were stopped at least 4 days 
before stool collection and blood sampling for serum bile acid analysis. 
Ileal resection — Ten subjects who had undergone ileal resection for Crohn's 
disease (7 male, 3 female; mean age: 42, range 24-57 Уг) participated in the 
study. Ileal resection had been performed 1 to 14 yr (median: 9 yr) before the 
time of this study. The diagnosis of Crohn's disease had been confirmed by 
histological examination of the surgical specimen in all patients. The length 
of the resected terminal ileum ranged from 30 to 70 cm (mean ± SEM: 44 ± 8 
cm). None of the patients had signs of active Crohn's disease or small bowel 
obstruction at the time of investigation. 
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Ileal pouch-anal anastomosis — Eleven patients who had undergone proctoco-
lectomy with ileal pouch-anal anastomosis (8 patients for ulcerative colitis 
and 3 for familial adenomatous polyposis coli; 7 male, 4 female; mean age: 
41, range 28-61 year) were studied. The patients had been operated on 2 to 7 
years (median: 6 years) before this study. 
78 
Informed consent was obtained from each subject and the protocol had been 
approved by the Ethical Committee of the Nijmegen University Hospital. 
None of the subjects had undergone cholecystectomy. Routine liver function 
tests were normal in all subjects and none of the subjects had been using anti-
biotics at least 3 weeks before the study. 
5.3.2 METHODS 
Analysis of scrum bile acids — Venous blood samples were collected after an 
overnight fast and were allowed to clot. After centrifugation scrum was fro-
zen at -20°C for subsequent analysis. Serum levels of the conjugated and 
unconjugated fractions of cholic (CA), chenodeoxycholic (CDCA) and deoxy-
cholic (DCA) acid were measured by capillary gas-liquid chromatography. An 
internal standard, 7a,i2a-dihydroxy-5-ßcholanoic acid, was added to the 
serum samples. Bile acids were extracted from serum using Ci8-bonded sili-
ca cartridges (SepPak, Waters Associates, Milford, MA, USA) (13). Separation 
of conjugated and unconjugated bile acids was carried out by means of 
column chromatography using the anion exchanger diethylaminohydroxy-
propyl Sephadex LH-20 (Lipidex-DEAP) (13). The conjugated fractions were 
subjected to enzymatic hydrolysis by cholylglycine hydrolase (from Clostridi-
um perjrincjens). The deconjugated bile acids were extracted and eluted on Lipi-
dex-1000 columns (14). The bile acids were converted to methyl esters by 2,2-
dimethoxypropane (Merck, Darmstadt, Germany). After methylation the 
trimethylsilyl ether dérivâtes were prepared by addition of a solution of 
pyridine, hexamethyldisilazane and trimethylchlorosilane (3:2:1 by vol.). 
Immediately before application to the gas Chromatograph the silylation 
reagent was dried under nitrogen and the samples were redissolved in 50 μι 
hexane. Two pL of this solution was used for injection. Separation and quan­
tification of individual bile acids was performed on a Packard 430 gas-liquid 
Chromatograph (Packard Instruments, Delft, The Netherlands) with a flame 
ionisation detector and equipped with a 25 m * 0.22 mm glass capillary 
column (CP-Sil-5 CB, Chrompack, Middelburg, The Netherlands). The Chro­
matograph was equipped with an automatic solid injection system. Helium 
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was used as carrier gas. The injection temperature was 285°C and the indivi-
dual bile acids were separated by computer based stepwise increment of 
column temperature from i50-29o°C. The flame ionisation temperature was 
28o°C. Bile acids were identified by the comparing retention times of the 
individual bile acids to those of reference bile acids. 
Bacterial examination qfjejunal jluid — Jejunal fluid was obtained by means of a 
gas-sterilized radio-opaque Polyvinylchloride tube after an overnight fast. 
Samples of jejunal fluid were collected 15 cm beyond the duodenojejunal 
junction. The position of the tube was checked fluoroscopically. To prevent 
contamination with saliva the tip of the tube was sealed with an agar plug. 
Before sampling the agar plug was expelled by inflating nitrogen through the 
tube. Immediately after sampling 0.5 ml of jejunal fluid was added to 4.5 ml 
of Wensinck medium containing 1.0 g glucose, 4.0 g starch, 10.0 g tryptose, 
5.0 g NaCl, 3.0 g K2HPO4, 0.5 g KH2PO4, 0.5 g MgS04) 0.5 g cysteine-HCl, 
and 3.0 g yeast extract dissolved in 1000 ml H2O. The procedure was continu-
ed in an anaerobic chamber with an oxygen tension of less than 5 ppm. (15). 
After homogenization, serial dilutions of the homogenate were spread on a 
non-selective agar plate with 7% blood obtained from sheep. Aerobic and 
anaerobic cultures were continued at 37°C for two and seven days respective-
ly. For aerobic cultures, four additional selective media (Mannitol salt agar, 
Kanamycin esculin azide agar, Sabouraud agar, Oxoid, Pharmachemie, Haar-
lem, The Netherlands and Levine EMB, Boom, Meppel, The Netherlands) 
were used. Counting of bacteria was done using the method described by 
Holdeman (16). 
Statistical analysis — Bile acid levels were expressed as mean, median and 
range. In order to test the hypothesis that unconjugated serum bile acids (CA, 
CDCA, DCA, total, and percentage unconjugated serum bile acids) were 
different in at least one of the patient groups the Kruskal-Wallis one-way 
AOV was used. If so, groups were compared pairwise using the Mann-
Whitney U-test to identify which of the groups were different from patients 
with bacterial overgrowth and from controls. A p-value <o.oi was considered 
statistically significant because of multiple comparisons. The mean of con-
trols plus at least two standard deviations was chosen as cut-off level between 
normal and elevated serum bile acid levels, unless stated otherwise. 
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5-4 Results 
5.4.1 BACTERIAL EXAMINATION OF JEJUNAL FLUID 
In all healthy subjects the sum of aerobic and anaerobic bacteria found in 
jejunal fluid was less than ιο6·5 per ml. In all patients with suspected small 
80 intestinal bacterial overgrowth the number of bacteria exceeded io 8 per ml 
(Table 5.1). 
5.4.2 INDIVIDUAL UNCONJUGATED SERUM BILE ACIDS 
Cholic acid — Unconjugated CA levels (Figure 5.1) were significantly higher in 
patients with small intestinal bacterial overgrowth (mean: 1.40, median: 
1.26, range 0.21-3.40 μΜ) compared to healthy controls (mean: 0.35, 
median: 0.20, range: 0.07 -1.37 μΜ, p<o.oooi), patients with coeliac disease 
(mean: 0.37, median: 0.34, range: 0.20-0.66 μΜ, р=о.ооз), patients with 
chronic pancreatitis (mean: 0.41, median: 0.31, range: 0.08-1.20 μΜ, 
p=o.oo4), and patients with ileal pouch-anal anastomosis (mean: 0.48, 
median: 0.39, range: 0.15-1.10 μΜ, p=o.oo6). However, there was a conside­
rable overlap between the groups. Unconjugated CA levels in patients with 
bacterial overgrowth were also higher compared to patients with ileal resec­
tion (mean: 0.54, median: 0.47, range: 0.07-Г.20 μΜ) but the difference did 
not reach statistical significance (p=o.oi2). No significant differences were 
observed between controls and patients with coeliac disease, chronic pancre­
atitis, ileal pouch-anal anastomosis, and patients with ileal resection. 
Chenodeoxycholic acid — Unconjugated CDCA levels (Figure 5.1) were 
significantly higher in patients with small intestinal bacterial overgrowth 
(mean: 1.52, median: 0.86, range 0.38-5.86 μΜ) compared to the healthy 
controls (mean: 0.32, median: 0.30, range: 0.07-0.78 μΜ, p<o.oooi), 
patients with coeliac disease (mean: 0.49, median: 0.47, range: 0.25-0.84 
μΜ, p=o.oo9), patients with chronic pancreatitis (mean: 0.33, median: 0.23, 
range: 0.05-0.96 μΜ, p=o.ooi), and ileal pouch patients (mean: 0.43, 
median: 0.40, range: 0.20-0.70 μΜ, р=о.ооз). However, there was a conside­
rable overlap between these groups. Unconjugated CDCA levels in patients 
with ileal resection (mean: 1.29, median: 1.37, range 0.22-2.24 μΜ) were 
significandy higher compared to controls (p=o.ooo5). No significant 
difference was observed between patients with bacterial overgrowth and 
patients with ileal resection (p=o.5g). No significant differences were ob­
served between controls and patients with coeliac disease, chronic pancreati­
tis, and ileal pouch-anal anastomosis. 
CHAPTER 5 
β.ο 
5.0 
4.0 
3.0 
2.0 
1.0 
0.0 
unconjugated 
о 
fr 
β 
о 
~j|-ï" 
CDCA (μιποΙ/Ι) 
О 
"Г 
fr 
о 
-іг-
8 
8 
О 
О 
8 __ 
8 
8і 
Contr SIBO CD CP IΡ AA IR Conti SISO CD CP IPAA IR 
4.0 
3.0 
2.0 
1.0 
η η 
unconjugated DCA (pmol/l) 
о 
8 i 
0 
6 
о 
0 0 
fr 
¿fe 
—*-
(β.7Β) 
а 
о 
<D 
«6° 
* І * 
• Τ » 
Figure 5.1. Unconjugated cholic acid 
(CA), chenodeoxycholic acid (CDCA), 
and deoxycholic acid (DCA) levels in con­
trols (Contr), patients with small inte­
stinal bacterial overgrowth (SIBO), coe-
liac disease (CD), chronic pancreatitis 
(CP), ileal pouch-anal anastomosis 
(IPAA), and in patients with ileal resec­
tion (IR). Error bars indicate mean ± 2sd. 
Conti SIBO CD CP IPAA IR 
Deoxycholic acid — Unconjugated DCA levels (Figure 5.1) were significantly 
higher in patients with small intestinal bacterial overgrowth (mean: 1.65, 
median: 0.95, range 0.06-8.76 μΜ) compared to healthy controls (mean: 
0.33, median: 0.29, range: 0.07-1.00 μΜ, p=o.ooi), patients with coeliac dis­
ease (mean: 0.28, median: 0.15, range: 0.05-1.13 μΜ, p=o.oi), patients with 
ileal pouch-anal anastomosis (mean: 0.19, median: 0.15, range: 0.10-0.40 
CHAPTER 5 
μΜ, ρ=ο.οοι), and patients with ileal resection (mean: 0.25, median: 0.25, 
range: 0.00-0.45 μΜ, p=o.ooi). Unconjugated DCA levels in patients with 
chronic pancreatitis (mean: 0.58, median: 0.64, range 0.25-0.99 μΜ) did not 
differ significantly from those in patients with bacterial overgrowth (p=o.o8). 
Again, there was a considerable overlap between patients with bacterial over-
82 growth and controls. No significant difference was observed between con­
trols and patients with coeliac disease, ileal resection, or ileal pouch-anal 
anastomosis. Unconjugated DCA levels were significantly higher in patients 
with chronic pancreatitis compared to controls (p=o.oo5). 
Total unconjugated serum bile acid levels — Total unconjugated serum bile acid 
levels (Figure 5.2) were significantly higher in patients with small intestinal 
bacterial overgrowth (mean: 4.57, median: 3.86, range 1.46-9.35 μΜ) 
compared to healthy controls (mean: 1.00, median: 0.93, range: 0.21-2.85 
μΜ, p<o.oooi), patients with coeliac disease (mean: 1.13, median: 1.01, 
range: 0.56-1.86 μΜ, p<o.ooi), patients with chronic pancreatitis (mean: 
1.31, median: 1.07, range: 0.80-2.43 MM, p<o.ooi), patients with ileal pouch-
anal anastomosis (mean: 1.10, median: 0.96, range: 0.47-1.90 μΜ, p<o.ooi), 
and patients with ileal resection (mean: 2.09, median: 2.24, range: 0.31-3.54 
Figure5.2. Total unconjuga­
ted serum bile acid levels 
(CA+CDCA+DCA) in controls 
(Contr), patients with small 
intestinal bacterial overgrowth 
(SIBO), coeliac disease (CD), 
chronic pancreatitis (CP), ileal 
pouch-anal anastomosis 
(IPAA), and patients with ileal 
resection (IR). Error bar indica­
tes mean ± 2sd. Cut-off level 
between normal and elevated 
total unconjugated bile acid 
levels was chosen at 2.5 μΜ. 
10.0 
total unconjugated bile acids (μΜ) 
Contr SIBO CD CP IPAA IR 
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μΜ, ρ=ο.οι8). Total unconjugated serum bile acid levels in patients with ileal 
resection were significantly higher compared to controls (p=o.oo6). No 
significant differences were observed between controls on the one hand and 
patients with coeliac disease, chronic pancreatitis, or ileal pouch-anal 
anastomosis on the other. 
When 2.5 μΜ was chosen as cut-off level between normal and elevated 83 
total unconjugated serum bile acid levels, 9 out of 11 patients with bacterial 
overgrowth had levels outside the normal range (sensitivity = 82%). In all 
patients with other malabsorption syndromes (8/8 patients with coeliac dise­
ase and ii/n with chronic pancreatitis) levels were within the normal range 
(specificity = 100%). The positive predictive value of elevated total unconjuga­
ted serum bile acids as a diagnostic criterium for small intestinal bacterial 
overgrowth in patients with malabsorption was 100% (9/9 patients). The 
negative predictive value was 90% (19/21 patients). The accuracy was 93% 
(28/30 patients). 
Individual unconjugated bile acids provided a poorer discrimination 
between patients and controls compared to total unconjugated bile acids. 
Unconjugated CA, CDCA, and DCA levels were outside the normal range in 7 
(64%) out of 11 patients with bacterial overgrowth (Figure 5.1). 
Figure 5.3. Percentage uncon­
jugated serum bile acid levels 
in controls (Contr), patients 
with small intestinal bacterial 
overgrowth (SIBO), coeliac 
disease (CD), chronic pancre­
atitis (CP), ileal pouch-anal 
anastomosis (IPAA), and 
patients with ileal resection 
(IR). Error bar indicates mean ± 
2sd. 
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Percentage unconjugated serum bile acid levels — Total unconjugated bile acids 
expressed as percentage of the sum of total conjugated and unconjugated bile 
acid levels (Figure 5.3) were significantly higher in patients with small inte-
stinal bacterial overgrowth (mean: 66, median: 69, range: 42-84%) compared 
to the healthy controls (mean: 40, median: 41, range 10-69%, p<o.ooi), 
84 patients with coeliac disease (mean: 27, median: 27, range: 12-51%, 
p<o.ooi), chronic pancreatitis (mean: 36, median: 42, range: 10-55%, 
p<o.ooi). In patients with ileal pouch-anal anastomosis (mean: 49, median: 
49, range: 30-74%, p=o.oi8) and ileal resection (mean: 53, median: 57, range 
30-66%, p=o.05) the percentage unconjugated serum bile acid levels tended 
to be lower compared to the patients with bacterial overgrowth, but the 
difference did not reach statistical significance. Again, discrimination 
between the groups was poor because of a considerable overlap. No 
significant differences were observed between controls and patients with 
coeliac disease, chronic pancreatitis, ileal pouch-anal anastomosis, or ileal 
resection. 
5.5 Discussion 
In small intestinal bacterial overgrowth conjugated bile acids are deconjuga-
ted in the small intestine by bacterial enzymes. This results in malabsorption 
of fat and fat-soluble vitamins since unconjugated bile acids lack the capacity 
to form micelles. Unconjugated bile acids are rapidly absorbed in the small 
intestine and are less effectively extracted from the portal blood by the liver 
than conjugated bile acids (17). 
Unconjugated bile acid levels in serum have been shown to be elevated in 
patients with small intestinal bacterial overgrowth (8-12,18). Lewis et al. (8) 
found elevated fasting total serum bile acid levels in patients with clinical 
signs of small intestinal bacterial overgrowth using thin layer chromatogra-
phy. This increase was almost entirely due to the presence of high unconjuga-
ted bile acid levels. Conjugated bile acid levels were normal or slightly eleva-
ted. More recently, Setchell (9) found markedly elevated unconjugated bile 
acid levels throughout the day in a patient with small intestinal bacterial over-
growth using gas-liquid chromatography. In this patient a remarkable predo-
minance of DCA and other secondary bile acids was found. 
Bolt and co-workers (10) studied unconjugated serum bile acid levels using 
both gas-liquid chromatography-mass spectrometry and enzymatic fluoro-
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metry in nine patients with a positive I4C-glycocholate breath test and clinical 
signs compatible with small intestinal bacterial overgrowth. Unconjugated 
serum bile acid levels were significantly higher in patients with bacterial over­
growth but there was a considerable overlap between patients and controls. 
Six out of nine patients had clearly elevated total unconjugated serum bile 
acid levels. When individual unconjugated bile acids were measured by gas- 85 
liquid chromatography-mass spectrometry, CA provided the best discrimina­
tion: eight out of nine patients had levels out of the normal range. CDCA and 
DCA levels were elevated in 6 and 4 patients, respectively. Thus, in contrast to 
the patient described by Setchell (9), there was no predominance of seconda­
ry bile acids in the serum of these patients. However, like in the former stu­
dies bacterial overgrowth was not validated by jejunal culture but by a I4C-gly-
cocholate breath test. The '4C-glycocholate breath test depends on bacterial 
cleavage of glycine from the conjugated bile acid, metabolism of the glycine 
moiety to ^CCh and measurement of I4C in breath samples. This test has a 
low specificity (7) because false positive results are obtained in patients with 
idiopathic bile acid malabsorption and after ileal resection. 
Masclee et al. (12) found significantly elevated total unconjugated serum 
bile acid levels using enzymatic fluorometry in patients with culture proven 
bacterial overgrowth compared to healthy subjects, patients with an accelera­
ted intestinal transit and patients who had undergone an ileal resection. The 
sensitivity of the test as a marker for bacterial overgrowth was 90%. 
In the present study, fasting total unconjugated serum bile acids were ele­
vated in 9 out of n patients with culture proven bacterial overgrowth (sensiti­
vity = 82%). Discrimination between patients and controls could not be 
improved by using individual unconjugated bile acid levels. Total unconjuga­
ted serum bile acids appeared to be within the normal range in all patients 
with other malabsorptive states (specificity = 100%), when 2.5 μΜ was cho­
sen as cut-offlevel. In patients with malabsorption, the positive and negative 
predictive values were roo% and 90% respectively. When specificity and pre­
dictive values were calculated in all non-operated subjects regardless of 
having malabsorption 42 out of 43 subjects without bacterial overgrowth had 
levels within the normal range (specificity = 98%). In this population positive 
and negative predictive values were 90% (9/10) and 95% (42/44) respectively. 
In contrast to Setchell (9) and in agreement with Bolt (12) we did not find a 
predominance of unconjugated secondary bile acids since unconjugated DCA 
levels were elevated in 7 out of 11 bacterial overgrowth patients, whereas both 
CA and CDCA levels were also elevated in 7 patients. 
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Probably as a result of spill-over into the colon, unconjugated CDCA levels 
were remarkably high in patients with ileal resection. However, CA and DCA 
levels were within the normal range. Total unconjugated serum bile acids were 
significantly higher in patients with ileal resection compared to controls. 
In conclusion, this study demonstrates that determination of fasting total 
86 unconjugated serum bile acid levels is a sensitive and specific marker for 
small intestinal bacterial overgrowth, and that determination of individual 
unconjugated bile acids offers no advantage in terms of sensitivity or 
specificity over total unconjugated serum bile acid levels. Mass-spectrometry 
in addition to gas-liquid chromatography appears to be redundant in the 
identification of patients with bacterial overgrowth. This implies a major 
simplification of bile acid analysis. After ileal resection unconjugated CDCA 
levels are elevated, probably as a result of spill-over into the colon. 
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6.1 Abstract 
In patients with ileal pouch anal anastomosis (IPAA) bile acid reabsorption 
may be impaired and stasis in the ileal pouch may lead to deconjugation and 
dehydroxylation of bile acids as a result of bacterial overgrowth. Therefore, 
90 we studied fasting and postprandial conjugated and unconjugated serum 
levels of cholic (CA), chenodeoxycholic (CDCA), and deoxycholic acid (DCA) 
in 11 patients who had undergone proctocolectomy with IPAA and in 11 heal-
thy controls. Fasting levels of conjugated DCA but not CA and CDCA were 
significantly lower in IPAA patients. Postprandial^, conjugated bile acid 
levels were significantly lower in IPAA patients. Postprandial unconjugated 
CA levels were significantly higher and CDCA levels tended to be higher in 
IPAA patients, whereas unconjugated DCA levels were lower in IPAA 
patients. These data suggest that reabsorption of conjugated bile acids is 
impaired after IPAA; that deconjugation of bile acids may result from bacte-
rial overgrowth secondary to stasis in the pouch; and that dehydroxylation of 
bile acids is decreased after proctocolectomy with IPAA. 
6.2 Introduction 
Proctocolectomy with ileal pouch-anal anastomosis (IPAA) is an attractive 
and widely accepted surgical alternative to permanent ileostomy or continent 
ileostomy in patients with severe chronic ulcerative colitis and familial ade-
nomatous polyposis since anal function is preserved and the necessity for 
permanent ileostomy is eliminated (1,2). Bile acid metabolism may be altered 
in these patients for several reasons. First, the terminal ileum, which is being 
used in the construction of the ileal reservoir, plays a key role in the reabsorp-
tion of conjugated bile acids. An increased fecal excretion of bile acids has 
been observed in patients with a Kock's continent ileostomy (3-5), and in 
IPAA patients (6,7). This suggests that ileal reabsorption of conjugated bile 
acids is impaired in these patients. Secondly, stasis of fecal contents in the 
ileal pouch may theoretically lead to bacterial overgrowth with abnormal 
deconjugation of bile acids. Finally, 7a-dehydroxylation of the primary bile 
acids cholic (CA) and chenodeoxycholic acid (CDCA) to the secondary bile 
acids deoxycholic (DCA) and lithocholic acid by colonic bacterial flora, is pro-
bably decreased after proctocolectomy. 
The aim of this study was to investigate whether proctocolectomy with 
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IPAA leads to alterations in absorption, deconjugation, and 7Ct-dehydroxyla-
tion of bile acids. Since systemic bile acid levels are proportional to the load 
of bile acids absorbed from the intestine (8,9) and postprandial conjugated 
serum bile acid levels increase rapidly in healthy subjects (10-12) fasting and 
postprandial serum bile acid levels were compared in IPAA patients and in 
healthy non-colectomized subjects. Both conjugated and unconjugated 91 
serum bile acid levels were measured since unconjugated bile acids levels are 
usually elevated in patients with small intestinal bacterial overgrowth (13-17). 
6.3 Subjects and methods 
Subjects — Eleven subjects who underwent proctocolectomy with IPAA (8 
ulcerative colitis and 3 familial adenomatous polyposis patients; 7 male, 4 
female; mean age: 41, range 28-61 year) and eleven healthy sex and age 
matched controls (7 male, 4 female; mean age 41, range 27-61 year) were stu-
died. Patients and controls were matched for age since postprandial serum 
levels of conjugated bile acids are influenced by ageing (18). The patients had 
been operated 2 to 7 years (median: 6 years) before this study. None of the 
IPAA patients had clinical signs of pouchitis at the time of investigation. 
None of the subjects had undergone cholecystectomy and none of the healthy 
subjects had a history of gastrointestinal disease. Routine liver function tests 
were normal in all subjects. Informed consent was obtained from each sub-
ject and the protocol had been approved by the Ethics Committee of the Nij-
megen University Hospital. 
Experimental protocol — All subjects fasted overnight and then ingested a stan-
dardized breakfast composed of one slice of bread, 5 g margarine, 20 g chee-
se, one boiled egg, 150 ml yogurt and one cup of tea with 5 g sugar (21 g pro-
tein, 21.5 g fat, 34 g carbohydrate, 413 kcal). Venous blood samples for analy-
sis of serum bile acid levels were taken at 0, 30,60,90,120,150,180,210, and 
240 minutes through an indwelling catheter placed in an antecubital vein. 
Blood samples were allowed to clot. After centrifugation the separated serum 
was frozen at -20°C for subsequent analysis. 
Analysis of serum bile acids — Serum bile acid levels were measured by capillary 
gas-liquid chromatography, a highly accurate and sensitive method (19). 
7oc,i2a-dihydroxy-5ßcholanoic acid was added as an internal standard. Bile 
CHAPTER 6 
acids were extracted from serum using Ci8-bonded silica cartridges (SepPak, 
Waters Associates, Milford, MA, USA) (20). Separation of conjugated and 
unconjugated bile acids was carried out by means of column chromatography 
using the lipophilic anion exchanger diethylaminohydroxypropyl Sephadex 
LH-20 (Lipidex-DEAP, Packard Instruments, Groningen, The Netherlands) 
92 (20). The conjugated fractions were subjected to enzymatic hydrolysis by cho-
lylglycine hydrolase (from Clostridium perjrincjens) (21). After enzymatic hydro-
lysis the deconjugated bile acids were extracted and eluted on Lipidex-iooo 
columns (Packard Instruments) (21). The bile acids were converted to methyl 
esters by 2,2-dimethoxypropane. After methylation trimethylsilyl ether déri-
vâtes were prepared by addition of a solution of pyridine, hexamethyl-
disilazane and trimethylchlorosilane (3:2:1 by vol.). Separation and 
quantification of bile acids was performed on a Packard 430 gas-liquid Chro-
matograph with a flame ionisation detector and equipped with a 25 m * 0.25 
mm glass capillary column (CP-Sil-5 CB, Chrompack, Middelburg, The 
Netherlands). 
Statistical analysis — Results were expressed as the mean + SEM. Bile acid cur-
ves were tested by standard repeated measurements analysis of variance. To 
eliminate skewness of the bile acid distribution a logarithmic transformation 
of the data was applied. Firstly, time effects were studied. Secondly, the hypo-
thesis that time effects were equal for both groups was tested. When time 
effects were equal the mean bile acid curves were considered to be parallel. 
When the bile acid curves were non-parallel time effects were described sepa-
rately for both groups. Integrated bile acid values (area under the curve) were 
compared with the two-tailed Student's t-test after logarithmic transforma-
tion to eliminate skewness in the distribution. A p-value <o.o5 was conside-
red statistically significant. 
6.4 Results 
Conjugated bile acids — Fasting levels of the conjugated primary bile acids (CA 
and CDCA) were similar in IPAA patients and controls. Fasting levels of con-
jugated DCA however, were significantly lower in the IPAA group. After the 
test meal levels of all individual conjugated bile acids increased more rapidly 
and to a higher extent in the control subjects compared to the IPAA patients 
(Figure 6.1). In IPAA patients conjugated DCA levels were extremely low 
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Table 6.1 Integrated conjugated serum bile acid levels in patients with ileal pouch-
anal anastomosis (IPAA) and healthy controls. 
controls (μΛ/l.min) IPAA (pM.min) significance level 
CA 272140 175 ±30 p<o.05 
CDCA 601 ±54 405 ±40 p<0.05 93 
DCA 270130 64 ±12 p<o.ooi 
Table 6.2 Integrated unconjugated serum bile acid levels in patients with ileal 
pouch-anal anastomosis (IPAA) and healthy controls. 
controls (μΛ/l.min) IPAA (μΛ/l.min) significance level 
CA 60 + 10 110 ±17 p<o.o5 
CDCA 89113 123 + 15 NS 
DCA 112 + 23 4 8 1 7 p<o.05 
compared to the primary bile acid levels and showed no postprandial increa­
se. Repeated measurement analysis revealed that the trends of all individual 
conjugated serum bile acid curves differed significantly between both groups 
(Figure 6.1). The integrated conjugated bile acid levels were significantly hig­
her in the healthy controls compared to the IPAA patients (Table 6.1). The 
ratio of the integrated levels of conjugated DCA and the sum of the integrated 
levels of conjugated CA and CDCA levels was significantly lower in the ileal 
pouch patients (mean ± SEM: 0.11 ± 0.02) when compared to the controls 
(0.34 ± 0.06; p<o.oo5). 
Unconjugated bile acids — Fasting unconjugated serum bile acids levels were 
not significandy different between both groups. Repeated measurements 
analysis revealed a significant postprandial increase of unconjugated DCA 
levels in the healthy subjects but not in IPAA patients whereas CA and CDCA 
levels showed no significant postprandial trend in both groups (Figure 6.2). 
The integrated unconjugated serum bile acid levels are shown in Table 6.2. 
Integrated CA levels were significandy higher in IPAA patients, whereas 
integrated DCA levels were significandy lower in the IPAA patients. Integra­
ted CDCA levels tended to be higher in the IPAA patients but the difference 
did not reach statistical significance. The ratio of the integrated levels of 
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Figure 6.ι Fasting and postprandial con­
jugated serum levels (mean ± S E M ) of 
cholic (CA), chenodeoxycholic ( C D C A ) 
and deoxycholic acid ( D C A ) in ileal pouch 
patients (open markers) and healthy 
controls (closed markers). All bile acid 
curves of both groups were non-parallel 
(CA: p<o.ooi, CDCA: p<o.oi; DCA 
p<o.ooi; repeated measurements 
analysis). 
unconjugated DCA and the sum of the integrated levels of unconjugated CA 
and CDCA levels was significantly lower in the IPAA patients (mean ± SEM: 
0.23 ± 0.03) when compared to the controls (0.94 ± 0.29; p<o.o5). 
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Figure 6.2 Fasting and postprandial 
unconjugated serum levels (mean ± 
SEM) of cholic (CA), chenodeoxycholic 
(CDCA) and deoxycholic acid (DCA) in 
ileal pouch patients (open markers) and 
healthy controls (closed markers). Time 
trends were significant for DCA 
(p<o.ooi), but not for CA and CDCA. 
None of the bile acids curves showed 
significant differences between both 
groups. 
6-5 Discussion 
In the present study fasting and postprandial serum levels of conjugated and 
unconjugated individual bile acids in patients who had undergone proctoco­
lectomy with IPAA were compared with those obtained in healthy non-colec-
tomized volunteers. Postprandial conjugated bile acid levels increased to a 
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lower extent in IPAA patients compared with the healthy subjects. This sug-
gests that reabsorption of bile acids is impaired after proctocolectomy with 
IPAA since systemic bile acid levels are thought to be proportional to the load 
of bile acids absorbed from the intestine (8,9). Malabsorption of bile acids 
might be expected in these patients for several reasons. Firsdy, the mucosa of 
g 6 ileal pouches show histologic signs of inflammation in the vast majority of 
patients (22). This may lead to an impaired reabsorption of conjugated bile 
acids with an increased loss of fecal bile acids. Secondly, reabsorption of con-
jugated bile acids may be impaired since the relative mucosal surface of the 
terminal ileum is smaller after construction of a reservoir. Finally, stasis in 
the ileal pouch may lead to bacterial overgrowth with abnormal deconjuga-
tion of bile acids. 
Fecal bile acid excretion after colectomy with conventional ileostomy, con-
tinent Kock's ileostomy, and IPAA has been studied by various groups (3-
7,23). Bile acid absorption, as determined by the fecal excretion of intrave-
nously administered I4C-cholic acid, was studied by Andersson et al. (3) in 
conventional ileostomy patients before and after conversion to a continent 
Kock's ileostomy. Fecal bile acid excretion increased more than two-fold 
after conversion to a Kock's pouch. Hylander et al. (4) found an increased 
fecal excretion of I4C after oral ingestion of I4C-glycocholic acid in both con-
ventional ileostomy patients and Kock's ileostomy patients compared to non-
colectomized healthy subjects. The fecal I4C excretion was higher in the con-
tinent ileostomy patients compared to the conventional ileostomy patients. 
Pulmonary I4CCh excretion was increased in patients with a Kock's pouch, 
but not in those with a conventional ileostomy. This suggests that bile acid 
reabsorption is impaired after both colectomy with conventional ileostomy 
and Kock's ileostomy and that bile acids are deconjugated as a result of bacte-
rial overgrowth in the ileal pouch. Go et al. (23) however, found no impaired 
reabsorption of bile acids in patients with a Kock's pouch using direct instal-
lation of 23-75Se-homotaurochohc acid (SeHCAT) into the ileal pouch. 
Pedersen et al. (6) found a significant higher excretion of bile acids in IPAA 
patients compared to healthy controls. IPAA patients excreted primary bile 
acids, whereas controls mainly excreted secondary bile acids. Natori et al. (7) 
found that the mean daily fecal bile acid output in IPAA and conventional 
ileostomy patients was 1.5 times that of healthy, non-colectomized volun-
teers. The output of secondary and unconjugated fecal bile acids was higher 
in IPAA patients compared to conventional ileostomy patients, suggesting 
that bacterial conversion is more prominent in IPAA patients. 
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The present study provides further evidence that reabsorption of conjuga­
ted bile acids is impaired in IPAA patients. Our data further suggest that con­
version of primary to secondary bile acids (7 cc-dehydroxylation) is decreased 
after proctocolectomy with IPAA since both conjugated and unconjugated 
DCA levels were extremely low in these patients. Integrated unconjugated CA 
levels were significantly higher in IPAA patients, suggesting that bacterial 97 
overgrowth in the ileal pouch leads to abnormal deconjugation of bile acids. 
The major long-term complication after ileal pouch-anal anastomosis is 
pouchitis, an non-specific inflammation of the ileal reservoir, occurring in 
11-44% of patients (24-28). The etiology of pouchitis is unclear but it has 
been suggested that stasis and bacterial overgrowth with deconjugation of 
bile acids in the reservoir may play a role in its pathogenesis (29,30). Patients 
with pouchitis usually respond favourably to treatment with metronidazole. 
Higher counts of anaerobic bacteria have been found in effluents of Kock's 
and ileoanal pouches compared to effluents from conventional ileostomies 
(31). However, culture of pouch effluents from patients with pouchitis did 
not reveal higher numbers of anaerobes compared to patients without 
pouchitis (32,33). Since pouchitis almost exclusively occurs in ulcerative coli­
tis patients but not in familial adenomatous polyposis patients several 
authors have suggested that pouchitis is a novel manifestation of ulcerative 
colitis (22,27,28). In the present study no essential differences were found 
between serum bile acid profiles in ulcerative colitis and familial polyposis 
patients. 
In conclusion, the postprandial rise of conjugated bile acid levels was 
significantly lower in patients with IPAA compared to that of the healthy con­
trols. The postprandial serum levels of unconjugated CA and CDCA were 
higher in the IPAA patients compared to the controls although in the case of 
CDCA the difference did not reach statistical significance. The postprandial 
unconjugated DCA levels, however, were significantly lower in the IPAA 
patients. These data suggest that reabsorption of conjugated bile acids is 
impaired after IPAA and that bile acids are deconjugated by bacteria in the 
ileal pouch. Bacterial overgrowth in the ileal pouch, however, does not lead to 
7 α-dehydroxylation, indicated by very low DCA levels in the IPAA patients. 
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7·ΐ Abstract 
The colon and rectum contain regulatory peptides in mucosal endocrine 
cells, which suggests a hormonal role. In animal studies colectomy leads to 
increased plasma levels of cholecystokinin. Little is known about the effects 
102 of proctocolectomy with ileal pouch-anal anastomosis (IPAA) on the release 
of cholecystokinin (CCK) in man. Therefore we studied the effects of this pro­
cedure on fasting, postprandial, and bombesin stimulated plasma CCK levels 
and gallbladder volumes. Ten patients who had undergone proctocolectomy 
with IPAA and 12 healthy volunteers participated in the study. Fasting and 
postprandial plasma CCK levels and gallbladder volumes were studied for 3 
hours at 15 min intervals. In a second experiment plasma CCK levels were 
measured before and during intravenous administration of bombesin in six 
ileal pouch patients and five healthy volunteers. Fasting plasma CCK levels 
were higher (p<o.o5) in IPAA patients (2.6 ± 0.3 pM) compared to controls 
(1.7 ± 0.2 pM). Integrated postprandial plasma CCK levels were also distinct­
ly higher (p<o.oi) in patients (978 ± 126 pM.i8omin) than in controls (588 ± 
60 pM.i8omin). Mean fasting gallbladder volume was significantly (p<o.oi) 
decreased in IPAA patients (18 + 2 mL) compared to controls (28 + 2 mL). 
Postprandial gallbladder emptying as measured by percentage change was 
similar in both groups. After infusion of bombesin, integrated plasma CCK 
responses were higher (p<o.o5) in patients (161 ± 20 pM.20min) than in con­
trols (90 + 12 pM.2omin). In conclusion: fasting, postprandial, and bombe­
sin stimulated plasma CCK levels are elevated in IPAA patients compared to 
controls. Fasting gallbladder volume is decreased after IPAA. These findings 
suggest that the colon contains a factor that inhibits the release of CCK. 
7.2 Introduction 
Proctocolectomy with ileal pouch-anal anastomosis (IPAA) is an attractive 
and widely accepted alternative to permanent ileostomy in patients operated 
upon for severe ulcerative colitis or familial adenomatous coli, since the nor­
mal route of defecation is preserved (1,2). Long-term functional results are 
generally gratifying as defecation frequency and degree of incontinence is 
acceptable in the majority of patients (3-7). 
The colon and rectum contain regulatory peptides in mucosal endocrine 
cells, which suggests a hormonal role (8). Harper et al. (9,10) demonstrated 
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that extracts from colonic and ileal mucosa of cats and pigs, markedly inhibi-
ted both pancreatic protein secretion and gallbladder contraction. Intralumi-
nal perfusion of the colon with nutrients induces endocrine effects (11-16). 
Perfusion of the colon with oleic acid inhibits the release of cholecystokinin 
(CCK) and pancreatic enzyme secretion in dogs (15). Moreover, it has been 
shown that subtotal colectomy results in an increased postprandial CCK relè- 103 
ase in rats and dogs (17,18). These findings suggest that the colon contains a 
factor that suppresses the release of CCK. Little is known, however, about the 
effects of proctocolectomy on gastrointestinal physiology and circulating gut 
hormone responses in man. 
The aim of this study was to examine the effect of proctocolectomy with 
IPAA on the release of CCK and gallbladder motility in man. Therefore, we 
have studied fasting and postprandial plasma CCK levels and gallbladder 
volumes (GBV) in IPAA patients. The results were compared with those 
obtained in healthy volunteers. In order to study the release of CCK indepen-
dently of a meal, we further have studied CCK secretion during intravenous 
administration of bombesin, a neuropeptide that potently stimulates the rele-
ase of CCK (19-21). 
7.3 Subjects and methods 
Subjects—Twelve healthy subjects (seven male and five female) and 10 patients 
who had undergone proctocolectomy with IPAA (three male and seven fema-
le; three cases of familial adenomatous coli and seven cases of ulcerative coli-
tis) were studied. In all patients a J-pouch had been constructed 6 months to 7 
years (median: 4 years) before this study was performed. The diverting loop 
ileostomy had been closed in all. None of the IPAA patients had experienced 
pouchitis. Mean age, weight, length, and body mass index (BMI) were similar 
in both groups (Table 7.1). None of the healthy subjects had a history of pre-
vious abdominal surgery or gastrointestinal disease and none of the IPAA 
patients had undergone cholecystectomy. Fasting plasma CCK levels were 
determined in an additional 5 IPAA patients and 3 healthy volunteers (both 
groups, total 15 subjects). To assess whether postprandial plasma CCK levels 
change with time of follow-up the correlation between the integrated 
postprandial plasma CCK levels and the length of time after operation was cal-
culated. Informed consent was obtained from each subject and the protocol 
was approved by the Ethics Committee of the Nijmegen University Hospital. 
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Table 7.1 Gender, mean age, weight, height and body mass index (BMI) of patients 
with ileal pouch-anal anastomosis (IPAA) and healthy volunteers (controls). No signi­
ficant differences between both groups were observed. 
Controls IPAA ρ value 
sex 7M.5F 7M.3F 0.67 
age (yr/range) 36.3(22-61) 35-7(22-49) 0.70 
weight (kg) 77 ±3 77 ±3 0.99 
height (m) 1.7710.03 1.75 ±0.03 0.78 
BMI (kg/m2) 24.9 ± 0.9 25.2 ± 0.9 0.80 
Experimental protocol — All subjects reported at 8:30 AM at the gastrointestinal 
research laboratory after an overnight fast. The subjects ingested a standardi­
zed breakfast (at t=o min) composed of one slice of bread, 5 g of butter, 20 g 
of cheese, one boiled egg, 150 mL yoghurt, and one cup of tea with 5 g of 
sugar (21 g of protein, 21.5 g of fat, 34 g of carbohydrate). Venous blood 
samples for analysis of plasma CCK levels were drawn before (at t=-5 and о 
min) and at 15-minute intervals from о to 120 min and at 30-minute intervals 
from 120 to 180 minutes after the meal through an indwelling catheter placed 
in an antecubital vein. Blood was collected into glass tubes containing EDTA. 
After centrifugation the separated plasma was frozen at -20 °C until analysis. 
GBV was measured at the same time points. 
In a second experiment, the response of plasma CCK to intravenous admi­
nistration of bombesin (5 ng/kg/min) was measured in 6 IPAA patients (two 
male, four female; mean age, 34 years, range 23 to 41 years) and 5 healthy 
volunteers (three male, two female; mean age, 47 years, range 43 to 53 years) 
after an overnight fast. Three of the six IPAA patients had also participated in 
the first experiment. None of the IPAA patients had experienced episodes 
with pouchitis. None of the healthy volunteers in the bombesin experiment 
had participated in the first experiment. Bombesin was administered through 
an indwelling catheter in an antecubital vein. Blood samples for determina­
tion of plasma CCK levels were drawn from a catheter in an antecubital vein 
in the opposite arm before and at 5-min intervals for 20 minutes during bom­
besin infusion. 
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Gallbladder emptying — GBV was measured by means of real-time ultrasono­
graphy with the sum of cylinders method using a computerized method (22). 
In this method the longitudinal scan of the gallbladder is divided into a series 
of cylinders of equal height, with diameters perpendicular to the longitudinal 
axis of the gallbladder image. The uncorrected volume is the sum of volumes 
of these separate cylinders. To correct for the displacement of the longitudi­
nal image of the gallbladder from the central axis, a correction factor is calcu­
lated from the longitudinal and transverse scans of the gallbladder. GBV is 
calculated by multiplication of the uncorrected volume with the square of the 
correction factor. Two longitudinal and two transverse images of the gal­
lbladder were obtained at each time point. The mean of two measurements 
was used for further analysis. The variation of GBV measurements using this 
method ranges from 6.2% to 10.0%. Gallbladder emptying and percentage 
gallbladder emptying were calculated using the following formulas: 
Maximum gallbladder emptying = GBVo - GBVmin 
Percentage gallbladder emptying = ioo%*(GBVo - GBVmin)/GBVo 
were GBVo = mean fasting GBV (average of GBV at t=-5 and 0 min) and 
GBVmin = smallest postprandial gallbladder volume. 
Plasma CCK-Ievels — CCK was measured in plasma by a sensitive and specific 
radioimmunoassay (23,24). The antibody employed (T204), was raised in 
rabbit after the fourth immunization with albumin-coupled crude porcine 
CCK, and used in a final dilution of 1:80,000. The antibody binds to all car-
boxy-terminal CCK-peptides containing the sulphated tyrosyl region. The 
antibody shows less than 2% cross-reactivity with sulphated gastrins and 
does not bind to unsulphated forms of gastrin or structurally unrelated pepti­
des, like insulin, secretin, pancreatic polypeptide, bombesin and neuroten­
sin. Synthetic I1CCK33 coupled to I25i-hydroxyphenylpropionic acid succin-
imide ester (Bolton-Hunter reagent) was used as label and as standard prepa­
ration. The detection limit of this assay is 0.5 pM. The intra-assay variation 
ranges from 4.6 to 11.5% and the inter-assay variation from 11.3 to 26.1%. 
Statistical analysis — Results were expressed as mean ± SEM. Fasting plasma 
CCK levels and fasting GBVs were calculated as the mean of two basal meas­
urements (-5 and о min). Integrated plasma CCK secretion in response to the 
meal or to bombesin infusion was determined by calculating the area under 
the plasma concentration-versus-time curve using the trapezoidal rule. Sta-
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tistical analysis was performed using Student's t-test for unpaired results or 
the rank sum test when appropriate. A two-tailed ρ value of less than 0.05 was 
considered statistically significant. The correlation between integrated 
postprandial plasma CCK levels and length of postoperative time of follow-
up was calculated with the Pearson correlation coefficient. 
7.4 Results 
Fasting and postprandial plasma CCK levels — Fasting plasma CCK levels were 
significantly higher (p<o.o5) in IPAA patients (2.6 ±0.3 pM) compared to the 
healthy controls (1.7 ± 0.2 pM). Postprandial^, plasma CCK levels increased 
rapidly and significantly in both groups. In healthy volunteers the mean peak 
plasma CCK level was 4.2 ± 0.5 pM and in IPAA patients 7.8 ± 1.1 pM 
(р=о.ооз). The mean time to peak plasma CCK levels was similar in both 
groups: 58 ± 12 min in healthy controls and 50 ± 11 min in IPAA patients (NS). 
Plasma CCK concentration versus time curves are shown in Figure 7.1. Inte­
grated postprandial plasma CCK levels were significantly higher (p<o.oi) in 
the IPAA patients (797 ± yy pM.i8omin) compared to the healthy controls 
(516 ± 57 pM.i8omin). Individual integrated postprandial plasma CCK levels 
are shown in Figure 7.2. The Pearson correlation coefficient between integra­
ted postprandial plasma CCK levels and time of postoperative follow-up was -
0.63 (p=0.052). 
Fasting gallbladder volumes and postprandial gallbladder emptying — Fasting 
GBVs were significantly smaller (p<o.oi) in IPAA patients (18 ± 2 mL) when 
compared to healthy controls (27 ± 2 mL). Individual fasting GBVs are shown 
in Figure 7.3. Mean fasting and postprandial GBVs are depicted in Figure 7.4. 
Maximum gallbladder emptying was 23 ± 2 mL in controls and 15 + 3 mL in 
IPAA patients (p<o.oi). The smallest GBVs were reached at 95 ± 13 min in 
IPAA patients (3 ± 1 mL), and at 81 ± 7 min (NS) in controls (5 ± 1 mL, NS). 
The percentage gallbladder emptying was similar in both groups (controls: 
82 ± 3%; IPAA patients: 81 ± 4%, NS). No correlation was observed between 
fasting gallbladder volume and time of postoperative follow-up. 
Plasma CCK responses to bombesin-infusion — Basal plasma CCK levels were 
similar in both groups (controls: 1.8 ± 0.3 pM, IPAA patients 1.8 ± 0.4 pM). 
During infusion of bombesin the integrated plasma CCK response was 
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Figure 7.1 Fasting and 
postprandial plasma CCK ver­
sus time curves (mean ± SEM) 
in controls (open markers) and 
IPAA patients (closed mar­
kers). 
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Figure 7.2 Individual inte-
grated postprandial plasma 
CCK levels in healthy con-
trols (open markers) and 
IPAA patients (closed mar-
kers). Integrated postpran-
dial CCK levels were signi-
ficantly higher in IPAA 
patients (p<o.oi). Error 
bars indicate standard 
deviation. 
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Figure 7.3 Individual fas­
ting CBVs in healthy con­
trols (open markers) and 
IPAA patients (closed mar­
kers). Error bars indicate 
standard deviation. Mean 
fasting CBV in the healthy 
controls (28 ± 2 mL) were 
significantly higher compa­
red to IPAA patients (18 + 2 
mL, p<o.oi). 
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Figure 7.4 Mean (± SEM) fas­
ting and postprandial CBVs in 
healthy controls (open mar­
kers) and IPAA patients (clo­
sed markers). Postprandial gal­
lbladder emptying as meas­
ured by percentage change 
was similar in both groups. 
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Figure 7.5 Plasma CCK 
response (mean ± SEM) to 
infusion of bombesin in 5 
healthy controls (open mar-
kers) and 6IPAA patients (clo-
sed markers). The integrated 
CCK response to bombesin I 0 9 
infusion was significantly 
higher in IPAA patients 
(p<o.05) 
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significantly higher (p<o.05) in IPAA patients (161 ± 20 pM.20min) compa-
red to controls (90 ± 12 pM.2omin). Figure 7.5 shows the mean plasma CCK 
time curves in five healthy controls and six IPAA patients before and during 
infusion of bombesin. 
7.5 Discussion 
In the present study we have demonstrated that postprandial and bombesin-
stimulated plasma CCK levels are increased after proctocolectomy with IPAA. 
To our knowledge this is the first time that the effect of proctocolectomy on 
plasma CCK levels and GBVs has been studied in human beings. Probably as 
a result of fasting hypercholecystokinaemia, lasting GBVs are decreased in 
IPAA patients. Basal plasma CCK levels were slightly, but significantly eleva-
ted after proctocolectomy compared to the healthy controls in our meal 
study. However, in the bombesin study plasma CCK levels were similar in 
both groups. This apparent discrepancy is likely to be due to the small num-
ber of subjects in the bombesin experiment compared to the meal study. The-
refore, the power to detect a true difference in basal plasma CCK levels may 
Plasma CCK (pM) 
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have been too low in the bombesin experiment (type II error). 
Previously, it has been demonstrated that subtotal colectomy results in an 
increased postprandial plasma CCK release in rats and dogs (17,18). Pancre-
atic weight, digestive enzyme concentration, and secretion capacity increase 
following large bowel resection in rats (25). These effects are supposed to be 
no induced by elevated plasma CCK levels. 
Several mechanisms may account for the increased CCK levels after proc-
tocolectomy. First, a negative feedback mechanism on the release of CCK 
exerted by an unknown inhibiting colonic factor may be eliminated after 
proctocolectomy. This hypothesis is supported by the finding that perfusion 
of the colon with oleic acid has been shown to inhibit pancreatic protein 
secretion in dogs (12), cats (13), and man (14,15). Inoue et al. (16) have 
demonstrated that this inhibition of pancreatic exocrine protein secretion in 
dogs is due, at least in part, to suppression of CCK release. Under normal 
conditions, however, nutrients like oleic acid do not enter the colon in con-
centrations used in these perfusion experiments. Therefore, it is unclear 
whether these nutrients play a functional role in a feedback control of proxi-
mal CCK release in healthy human beings. 
Lluis et al. (26) have shown that a substance released from the colon inhi-
bits pancreatic secretion by inhibiting CCK release in dogs. This substance, 
peptide YY (PYY), has been found primarily in mucosal endocrine cells in the 
ileum, colon, and rectum of several species (27-29) including man (30). The-
refore, proctocolectomy may lead to lower circulating PYY levels and hence to 
elevated plasma CCK levels in human beings. Indeed, fasting PYY levels have 
been found to be decreased in patients who had undergone total colectomy 
(31) or colonic resection with ileostomy (32). This topic however, remains 
controversial since Armstrong et al. (33) have found increased fasting and 
postprandial plasma PYY levels as well as increased tissue levels of PYY one 
year after proctocolectomy with IPAA in dogs. It was suggested that an incre-
ased synthesis and release of PYY is an adaptive process that may contribute 
to a functional improvement by slowing small intestinal transit. This sugge-
stion is supported by studies of Pietroletti et al. (34), who found elevated fas-
ting and postprandial PYY levels after proctocolectomy with IPAA in humans. 
Although not of enough statistical power (p=o.o52), we found a trend 
towards declining CCK levels with time postoperatively, probably as a result 
of adaptation. It could be speculated that during follow-up after proctocolec-
tomy PYY synthesis in the terminal ileum and circulating PYY levels gradually 
increase as a result of adaptation. Assuming a suppressive effect of PYY on the 
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release of CCK, plasma CCK levels may initially increase after proctocolecto-
my and gradually decline during follow-up. 
Previous studies have shown that ileal perfusion of fat emulsions markedly 
inhibits gastric emptying, small bowel transit, and jejunal motor activity (35-
37). This 'ileal brake' correlates well to increased plasma levels of PYY (37). 
Intravenous infusion of PYY at physiological levels slows the mouth to i n 
caecum intestinal transit and the rate of gastric emptying (38,39). These data 
suggest that the ileal brake may be mediated by PYY. Small intestinal transit is 
also slowed in IPAA patients (40). It could be speculated that elevated PYY 
levels mediate this inhibition of small intestinal transit. Removal of the colon 
does not eliminate the ileal brake because it has been shown that oleic acid 
infusion into the ileal pouch slows gastric emptying and small intestinal 
transit and increases plasma levels of PYY (41,42). However, it is unclear to 
what extent stool frequency is influenced by the ileal brake mechanism 
following proctocolectomy with IPAA. As a result of inflammation of the ileal 
mucosa, the production of PYY might be decreased in patients with pouchitis. 
This might contribute to a rapid small intestinal transit and increased stool 
frequency in these patients. 
Previously, we have reported that postprandial conjugated serum bile acid 
levels are decreased in IPAA patients compared to healthy subjects with an 
intact colon (43). An increased fecal excretion of bile acids has been observed 
in patients with a Kock's continent ileostomy (44-46) and in IPAA patients 
(47,48). Probably, bile acids are reabsorbed less effectively by the ileal-pouch 
mucosa in comparison to the mucosa of the normal terminal ileum. The bile 
acid pool and the bile acid output into the duodenum decrease if fecal losses 
are substantial. Because the release of CCK is inhibited by bile acids in the 
duodenal lumen (49,50), elevated plasma CCK concentrations after procto-
colectomy may also be due to a decreased load of bile acids in the proximal 
part of the small intestine. 
In conclusion, basal, postprandial, and bombesin stimulated plasma CCK 
levels are elevated after proctocolectomy with ileal pouch-anal anastomosis 
in humans. Probably as a result, fasting GBVs are decreased after proctoco-
lectomy. The mechanisms responsible for hypercholecystokinaemia in IPAA 
patients are still incompletely understood, and need further investigation. 
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8.1 Abstract 
The aim of this study was to examine whether ileal resection leads to altera­
tions in bile acid absorption, deconjugation, 7oc-dehydroxylation, and forma­
tion of ursodeoxycholic acid (UDCA), and whether ileal resection affects 
118 plasma cholecystokinin (CCK) concentrations and gallbladder motility. The­
refore, we have determined fasting and postprandial conjugated and uncon­
jugated serum bile acid levels, plasma CCK levels, and gallbladder volumes in 
8 patients who had undergone ileocaecal resection for Crohn's disease and in 
12 healthy volunteers. After ileal resection, postprandial conjugated cholic 
(CA) and chenodeoxycholic acid (CDCA) levels were decreased and conjuga­
ted deoxycholic acid (DCA) levels were extremely low compared to controls. 
Unconjugated CA and CDCA levels were increased after ileal resection, whe­
reas unconjugated DCA levels were similar in both groups. Unconjugated 
UDCA was present in the serum of б of the 8 patients with ileal resection but 
in none of the healthy volunteers (p<o.oi). Fasting and postprandial CCK 
levels and gallbladder volumes were similar in both groups. These data 
demonstrate that ileal resection leads to malabsorption and increased decon­
jugation of conjugated bile acids, decreased 7a-dehydroxyIation, and in­
creased formation of UDCA. ileal resection does not alter the release of CCK 
and gallbladder motility. 
8.2 Introduction 
Interruption of the enterohepatic circulation by ileal resection leads to bile 
acid malabsorption and spill-over of bile acids into the colon. This is associa­
ted with increased fecal bile acid losses (1-5) and bile acid induced diarrhoea 
(1,6,7). Patients with Crohn's disease, particularly those with a history of dis­
tal ileitis or ileal resection, have an increased risk for cholelithiasis (8-13), 
possibly as a result of a decreased bile acid pool and a subsequent increase of 
biliary cholesterol saturation. Various data on bile lithogenicity in patients 
with Crohn's disease have been published. Most studies have reported a high 
frequency of cholesterol supersaturated bile (14-17), while others have found 
a decreased biliary cholesterol saturation in patients with Crohn's disease 
with ileal resection or ileal dysfunction (i8,io). 
Postprandial serum levels of conjugated cholic (CA) and chenodeoxycholic 
(CDCA) acid have been shown to be decreased after ileal resection (20-25). 
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However, little is known about the effect of ileal resection on deoxycholic acid 
(DCA), ursodeoxycholic acid (UDCA), and unconjugated serum bile acid 
levels. Lapidus and Einarsson have recently found a pronounced increase in 
the biliary UDCA fraction after ileal resection (19), which suggested that ileal 
resection should not lead to an increased risk of cholesterol gallstones. 
The aim of the present study was to examine whether ileal resection leads 119 
to alterations in bile acid absorption, deconjugation, 7o:-dehydroxylation, 
and formation of UDCA. Therefore, we have studied fasting and postprandial 
serum levels of conjugated and unconjugated individual bile acids in patients 
with Crohn's disease who had undergone partial ileal resection and right 
hemicolectomy. These data were compared to those obtained in healthy, 
non-operated volunteers. Serum bile acids were determined by capillary gas-
liquid chromatography, a highly sensitive and accurate method for serum 
bile acid analysis (26). 
Additionally, we studied fasting and postprandial plasma cholecystokinin 
(CCK) levels and gallbladder volumes in both groups. Intraduodenal bile 
acids are known to exert an inhibitory effect on the release of CCK (27-30). 
Since the output of bile acids into the duodenum has been shown to be decre­
ased after ileal resection (15), we have tested the hypothesis that ileal resec­
tion may lead to increased cholecystokinin levels and decreased fasting gal­
lbladder volumes. 
8.3 Subjects and methods 
Subjects — Eight subjects who had undergone partial resection of the terminal 
ileum in conjunction with partial right hemicolectomy for Crohn's disease (5 
male, 3 female; mean age: 39, range 24-54 years) and 12 healthy controls (8 
male, 4 female; mean age 43, range 22-70 years) participated in this study. 
Ileal resection had been performed 1 to 14 years (median: 9 years) before the 
time of this study. The diagnosis of Crohn's disease had been confirmed by 
histological examination of the surgical specimens in all patients. The length 
of the resected terminal ileum ranged from 30 to 70 cm (mean ± SEM: 44 + 8 
cm). None of the patients had signs of active Crohn's disease at the time of 
investigation. None of the subjects had undergone cholecystectomy and none 
of the healthy subjects had a history of gastrointestinal disease. Routine liver 
function tests (bilirubin, alkaline phosphatase, γ-glutamyltransferase) were 
normal in all subjects. None of the subjects had steatorrhoea (fecal fat excre-
CHAPTER 8 
don in excess of 7 g/day as measured in a 48 hr stool sample). None of the 
subjects was using cholestyramine or other drugs at the time of investigation. 
Informed consent was obtained from each subject and the protocol had been 
approved by the Ethics Committee of the Nijmegen University Hospital. 
120 Experimental protocol — All subjects fasted overnight and then ingested a stan-
dardized breakfast composed of one slice of bread, 5 g margarine, 20 g 
cheese, one boiled egg, 150 ml yogurt and one cup of tea with 5 g sugar (21 g 
protein, 21.5 g fat, 34 g carbohydrate, 413 kcal). Venous blood samples for 
analysis of serum bile acids and plasma CCK concentrations were taken at -5, 
o, 15,30,45, 60,75, 90,105,120,150, and 180 minutes through an indwelling 
catheter placed in an antecubital vein. Blood samples were allowed to clot. 
After centrifugation the separated serum was frozen at 20°C for subsequent 
analysis. 
Analysis ofserum bile acids — Serum bile acid levels were measured by capillary 
gas-liquid chromatography (26). 70c, i2a-dihydroxy-5-ßcholanoic acid was 
added as an internal standard. Bile acids were extracted from serum using 
Ci8-bonded silica cartridges (SepPak, Waters Associates, Milford, MA, USA) 
(31). Separation of conjugated and unconjugated bile acids was carried out by 
means of column chromatography using the lipophilic anion exchanger 
diethylaminohydroxypropyl Sephadex LH-20 (Lipidex-DEAP, Packard Instru-
ments, Groningen, The Netherlands) (31). The conjugated fractions were 
subjected to enzymatic hydrolysis by cholylglycine hydrolase (from Clostridi-
um perfrimjens). After enzymatic hydrolysis the deconjugated bile acids were 
extracted and eluted on Lipidex-iooo columns (Packard Instruments, Gro-
ningen, The Netherlands). The bile acids were converted to methyl esters by 
2,2-dimethoxypropane. After methylation trimethylsilyl ether dérivâtes were 
prepared by addition of a solution of pyridine, hexamethyldisilazane and tri-
methylchlorosilane (3:2:1 by volume). Separation and quantification of bile 
acids was performed on a Packard 430 gas-liquid Chromatograph with a 
flame ionisation detector and equipped with a 25 m * 0.25 mm glass capillary 
column (CP-Sil-5 CB, Chrompack, Middelburg, The Netherlands). 
Plasma cholecustokinin leuels — CCK was measured in plasma by a sensitive and 
specific radioimmunoassay (32,33). The antibody employed (T204), was rai-
sed in rabbit after the fourth immunization with albumin-coupled crude por-
cine CCK, and used in a final dilution of 1:80,000. The antibody binds to all 
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carboxy-terminal CCK-peptides containing the sulphated tyrosyl region. The 
antibody shows less than 2% cross-reactivity with sulphated gastrins and 
does not bind to unsulphated forms of gastrin or structurally unrelated pepti­
des, like insulin, secretin, pancreatic polypeptide, bombesin and neuroten­
sin. Synthetic human CCK33 was used as standard preparation and coupled to 
I25i-hydroxyphenylpropionic acid succinimide ester (Bolton-Hunter reagent) 121 
also as label. The detection limit of the assay was between 0.5 an 1 pM in plas­
ma. The intra-assay variation ranged from 4.6 to 11.5% and the inter-assay 
variation from 11.3 to 26.1%. 
Gallbladder emptying — Gallbladder volumes were measured by real-time 
ultrasonography by the sum of cylinders method using a computerized 
method as previously described (34). The variation of volume measurements 
ranged from 4.6 to 11.5%. Two longitudinal and two transverse images of the 
gallbladder were obtained at each time point. The mean of two measure­
ments was used for further analysis. Gallbladder emptying parameters were 
calculated using the following formulas: 
Maximum gallbladder emptying = GBVo - GBVmin 
Percentage gallbladder emptying = ioo%*(GBVo - GBVmm)/GBVo 
Where GBVo represents mean fasting gallbladder volume (mean of GBV at -5 
and 0 min), and GBVmin represents the smallest postprandial gallbladder 
volume. 
Statistical analysis — Results were expressed as mean ± SEM. Integrated bile 
acid values (area under the curve), fasting bile acid levels, fasting and 
postprandial plasma CCK levels, and gallbladder volumes were compared 
with the two-tailed Student's t-test for unpaired observations or the Mann-
Whitney U test when appropriate. A p-value <o.05 was considered statistical­
ly significant. 
8.4 Results 
Conjugated serum bile acids — Fasting and postprandial conjugated serum bile 
acid levels are shown in Figure 8.1. Fasting levels of conjugated CA (controls: 
0.37 + 0.04 μΜ; ileal resection: 0.43 ± 0.07 μΜ, NS) and CDCA (0.70 + 0.11 
μΜ and 0.82 ± 0.14 μΜ respectively, NS) were similar in both groups. Fasting 
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Figure 8.7 Fasting and postprandial con-
jugated serum levels (mean ± SEM) of 
cholic (CA), chenodeoxycholic (CDCA) 
and deoxycholic acid (DCA) in patients 
with ileal resection (open markers) and 
healthy controls (closed markers). Inte-
grated CA, CDCA, and DCA levels were 
significantly decreased in the resected 
patients. 
0 30 во 90 120 150 180 
Time (min) 
DCA levels however, were slightly decreased after ileal resection (0.21 ± 0.04 
μΜ) when compared to the healthy subjects (0.38 ± 0.07 μΜ), but the 
difference did not reach statistical significance (p=o.o9). Postprandially, all 
individual conjugated bile acid levels increased rapidly and significantly in 
the healthy volunteers. In the patients with ileal resection however, CA and 
DCA levels did not increase while CDCA levels increased to a lesser extent 
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compared to the healthy subjects. In the ileectomized patients postprandial 
DCA levels were extremely low compared to the healthy volunteers. The ratio 
of the integrated DCA to CA levels was significandy lower in the ileectomized 
patients (mean + SEM: 0.47 + 0.07) compared to the healthy subjects (1.17 ± 
0.18; p<o.oo5). The integrated levels of all individual conjugated bile acids 
were significandy higher in the healthy subjects compared to the patients 
with ileal resection (Table 8.1). Conjugated UDCA was not detected or pre­
sent in trace amounts in both patients and controls. 
Table 8.1 Integrated conjugated serum bile acid levels in healthy volunteers and 
patients with ileal resection (IR). Values are mean ± SEM. ND = not detected. 
CA 
CDCA 
DCA 
UDCA 
185.4 + 26.2 
453.6 ± 67.3 
194.1124.8 
ND 
controls (μΜ.πι'ιη) IR (μΜ.Γηίη) 
83.2 ±31.9 
2757 ± 427 
35-8 ± 5 4 
ND 
significance level 
p<o.oo5 
p<0.05 
p<0.0001 
Unconjugated serum bile acids — Fasting serum levels of unconjugated CA (con­
trols: 0.31 ± 0.06 μΜ; ileal resection: 0.47 ± 0.09 μΜ, NS) and DCA (controls: 
0.32 ± 0.06 μΜ, ileal resection: 0.28 ± 0.05 μΜ, NS) levels were similar in 
both groups but CDCA levels were higher in the ileal resection patients (con­
trols: 0.32 + 0.04 μΜ; ileal resection: 1.07 + 0.22 μΜ, p=o.oi). Fasting and 
postprandial unconjugated serum bile acid levels are shown in Figure 8.2. 
Integrated unconjugated bile acid levels are shown in Table 8.2. The Integra­
ted CA and CDCA levels were significantly higher in the ileal resection 
patients. Integrated DCA levels were similar in both groups. The ratio of the 
integrated unconjugated DCA to CA levels was significandy lower in the ope­
rated patients (mean + SEM: 0.68 ± 0.08) compared to controls (1.66 ± 0.25; 
p<o.oo5). In six of the operated patients unconjugated UDCA was detected in 
serum, butin none of the healthy subjects (p<o.oi). 
Fasting gallbladder uolume and postprandial gallbladder emptying — None of the 
subjects had gallstones. Fasting gallbladder volume was similar in both 
groups (controls: 28 ± 3 mL; ileal resection: 27 ± 7 mL, NS). Mean fasting and 
postprandial gallbladder volumes are shown in Figure 8.3. Maximum gall-
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Figure 8.2 Fasting and postprandial unconjugated serum levels (mean ± SEM) of 
cholic (CA), chenodeoxycholic (CDCA),deoxycholic acid (DCA), and ursodeoxycho­
lic acid (UDCA) in patients with ileal resection (open markers) and healthy controls 
(closed markers). Integrated unconjugated CA and CDCA levels were significantly 
higher in patients with ileal resection. Unconjugated DCA levels were similar in both 
groups. UDCA was not detected in controls. 
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Table 8.2 Integrated unconjugated serum bile acid levels in healthy volunteers and 
patients with ileal resection (IR). Values are mean ± SEM. ND = not detected. 
CA 
CDCA 
DCA 
UDCA 
controls (μΛ/l.m/n) IR (μΛ/l.mín) 
43.7 ±6.2 
60.1 ±7.3 
65.218.9 
ND 
97.4 ± 22.7 
232.9151.3 
56.1 ±7.2 
1436 ± 536 
significance level 
p<o.05 
p<0.01 
NS 
p<o.oi 
Gallbladder volume (itiL) 
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Figure 8.3. Fasting and 
postprandial gallbladder volu-
mes (mean ± SEM) in patients 
with ileal resection (open mar-
kers) and healthy controls 
(closed markers). Fasting gal-
lbladder volume and postpran-
dial gallbladder emptying were 
similar in both groups. 
bladder emptying was 22 + 2 mL in controls and 23 ± 7 mL in the ileectomized 
patients (NS). The percentage gallbladder emptying was similar in both 
groups (controls: 78 ± 3%; ileal resection: 83 ± 5%, NS). 
Fasting and postprandial plasma cholecystokinin levels — Fasting plasma CCK 
levels were similar in controls (3.4 ±0.2 pM) and the patients with ileal resec-
tion (3.4 ± 0.2 pM). Postprandially, plasma CCK levels increased rapidly in 
both groups. The mean peak plasma CCK level was 6.7 ± 0.8 pM in the 
healthy subjects and 6.8 ± 0.7 pM in the ileectomized patients (NS). Plasma 
CCK concentration versus time curves are shown in Figure 8.4. Integrated 
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postprandial plasma CCK levels were similar in both groups (controls: 898 ± 
73 pM.min; ileal resection: 961 +130 pM.min, NS). 
Figure 8.4. Fasting and 
postprandial plasma cholecys-
tokinin (CCK) (mean ± SEM) 
in patients with ileal resection 
(open markers) and healthy 
controls. Fasting and postpran-
dial CCK levels were similar in 
both groups. 
0 30 60 90 120 150 180 
Time (min) 
8.5 Discussion 
In accordance with previous studies, the present study demonstrates that 
postprandial conjugated bile acid levels are decreased in patients with 
Crohn's disease who have undergone ileal resection. These data provide 
further evidence that resection of the terminal ileum causes malabsorption of 
bile acids since systemic bile acid levels reflect portal venous bile acid levels 
(20,35). 
Postprandial conjugated CA levels showed virtually no increase in patients 
with ileal resection. Conjugated CDCA levels however, increased significantly 
both in patients and healthy subjects, but the rise in the patients with ileal 
resection was significantly lower compared to the healthy subjects. This sup-
ports the hypothesis that CDCA is reabsorbed both passively throughout the 
small intestine and actively in the terminal ileum, whereas reabsorption of 
conjugated CA is fully dependent on an intact terminal ileum (35-37). 
In former studies, postprandial serum bile acid levels in patients with ileal 
126 
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resection have been measured using radioimmunoassays for the glycine con-
jugates of CA and CDCA (20-25). Radioimmunoassay for serum bile acid ana-
lysis is rather insensitive, and inaccurate because of cross-reactivity between 
CA and CDCA. Moreover, at present little information is available on serum 
levels of conjugated DCA and unconjugated bile acids in patients with ileal 
resections. Therefore, we used capillary gas-liquid chromatography combi-
ned with lipophilic anion exchanger column chromatography. This method 
is highly sensitive and offers the opportunity of measuring both the conjuga-
ted and unconjugated fractions of all major bile acids in serum (26,31). 
Conjugated DCA levels were extremely low after ileal resection and the 
ratio of integrated levels of DCA to CA (both conjugated and unconjugated) 
was significantly decreased after ileal resection. Low DCA levels after ileal 
resection are probably due to a reduced exposure of CA to bacterial 7cx-dehy-
droxylase as a result of rapid colonic transit. This is supported by studies on 
fecal bile acid patterns in patients with Crohn's disease showing a low excre-
tion of DCA and an increased excretion of CA (2,38). Moreover, decreased 
molar percentages of DCA in bile have been found after ileal resection 
(15,19). 
The increased risk for cholelithiasis in patients with ileal dysfunction or 
ileal resection has been attributed to a decreased bile acid pool and increased 
of biliary cholesterol saturation. However, Lapidus and Einarsson (19) found 
a low biliary cholesterol saturation and a more than tenfold increase in the 
relative concentration of ursodeoxycholic acid in bile after ileal resection. 
Since UDCA treatment of patients with gallstones may induce biliary choles-
terol unsaturation and gallstone dissolution, they suggested that there 
should be no increased risk of cholesterol gallstone formation in patients 
with Crohn's disease and a history of ileal resection. Our findings give sup-
port to their data since UDCA was detected in sera of 6 of the 8 patients with 
ileal resections, but in none of the healthy subjects. 
UDCA is the 7ß-hydroxyepimer of CDCA and is usually present only in 
small amounts in human bile. UDCA is formed from CDCA acid with 
7-ketolithocholic acid as an intermediate. In the colon CDCA is oxidized to 
7-ketolithocholic acid, which is subsequently reduced to UDCA by bacterial 
enzymes (39-41). Miwa et al. (39) demonstrated that the incorporation of 
deuterium into biliary UDCA in patients with Crohn's disease is increased 
after ingestion of deuterated CDCA. Therefore, malabsorption of CDCA in 
patients with ileal resection or ileal dysfunction may favour the formation of 
UDCA acid in the colon. 
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Integrated unconjugated CA and CDCA levels were significantly higher in 
patients with ileal resection, probably as a result of spill-over to the colon 
with deconjugation by the colonic flora. It is well known that unconjugated 
bile acids are reabsorbed by the colon (42,43). Although unconjugated serum 
bile acids levels are usually elevated in patients with small intestinal bacterial 
overgrowth (44-48) it is unlikely that this condition is responsible for the 
increased unconjugated CA and CDCA levels in our patients. None of our 
patients had either small bowel obstruction or steatorrhoea. The late increase 
of unconjugated CA and CDCA levels (Figure 8.2) also suggests deconjuga-
tion and subsequent absorption in the colon. 
Intraduodenal bile acids exert a negative feedback on the release of CCK 
from the duodenum (27-30). Although the liver increases bile acid produc-
tion after interruption of the enterohepatic circulation, the intraduodenal 
output of bile acids has been shown to be decreased (15). In the present study 
however, plasma CCK levels and gallbladder volume were similar in patients 
with ileal resection and controls. 
In conclusion, postprandial conjugated bile acids are significantly decre-
ased after ileal resection. This provides further evidence that ileal resection 
leads to malabsorption of conjugated bile acids. Formation of DCA is reduced 
after ileal resection, probably as a result of a decreased colonic transit time 
and a shortened exposure to bacterial 7a-dehydroxylase. Bile acid deconjuga-
tion however, is increased after ileal resection. Spill-over of conjugated bile 
acids into the colon leads to increased deconjugation and increased unconju-
gated serum bile acid levels. Probably as a result of CDCA malabsorption, the 
production of UDCA is increased in most patients with ileal resection. Bile 
acid malabsorption after ileal resection does not lead to alterations in CCK 
release, fasting gallbladder volume, and gallbladder emptying. 
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Summary 
Since the early 1980s proctocolectomy with ileal pouch-anal anastomosis is 
the surgical treatment of choice for severe chronic ulcerative colitis and fami-
lial adenomatous polyposis. It enables the excision of the entire diseased 
colorectal mucosa with preservation of continence and avoidance of a perma-
nent ileostomy. 
Chapter 2 — Chapter 2 presents a review of the literature concerning the ileal-
pouch procedure. The most important postoperative complications and the 
long-term functional results are discussed. Comparative studies have shown 
that the results of the ileal pouch procedure are more favourable in polyposis 
patients compared to ulcerative colitis patients. Recent developments in 
pouch surgery, especially the use of new stapling devices, have made it 
possible to perform a one step procedure. Previously, a temporary diverting 
loop ileostomy was created to reduce the risk of anastomotic leakage and pel-
vic sepsis. A second operation was necessary to close the temporary ileosto-
my at the expense of a considerable complication rate. 
The major long-term complication of ileal pouch-anal anastomosis is 
pouchitis. Pouchitis is an a non-specific inflammation of the ileal mucosa in 
the pouch with a high recurrence rate. Clinically, pouchitis is characterized 
by an increased stool frequency, bleeding, abdominal pain, fatigue, fever, 
erythema nodosum, and arthritis. The etiology of pouchitis is unknown. Bac-
terial overgrowth as a result of stasis in the pouch may contribute to the 
pathogenesis of pouchitis since many patients respond favourably to metron-
idazole. In most studies pouchitis occurred exclusively in ulcerative colitis 
patients. This suggests that pouchitis is a novel manifestation of inflammato-
ry bowel disease. 
Finally, some physiological aspects of proctocolectomy with ileal pouch-
anal anastomosis, are discussed. 
Chapter 3 — In chapter 3 we compared the immediate postoperative and long-
term functional results of 51 ulcerative colitis patients and 21 familial adeno-
matous polyposis patients who underwent ileal J-pouch anal-anastomosis in 
the University Hospital Nijmegen between 1983 and 1990. Since familial 
polyposis patients are usually in a better physical condition and not using 
corticosteroids at the time of proctocolectomy, the incidence of postoperative 
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complications is likely to be lower in these patients than in ulcerative colitis 
patients. However, in this population the incidence of postoperative compli-
cations requiring relaparotomy was similar in both groups. Pouchitis was the 
major long-term complication. Pouchitis occurred in 44% of colitis patients 
but not in polyposis patients (p<o.oo5). Six colitis patients required pouch 
excision because of intractable pouchitis. The overall pouch excision rate was 
22% in ulcerative colitis patients and 5% in familial polyposis patients 
(p=o.i6). The mean daily stool frequency was significantly higher in colitis 
patients. Incontinence during daytime was rare. However, during nighttime 
16 colitis patients (43%) and 6 (34%) polyposis patients required a pad becau-
se of soiling or incontinence (not significant). Patient satisfaction was good 
in 46% of ulcerative colitis patients and 76% of polyposis patients (p<o.o5). 
Chapter 4 — In this chapter the effects of ageing on serum bile acid levels are 
described. Previously, it has been shown that the formation of deoxycholic 
acid is increased in elderly subjects. It has been suggested that cholic acid is 
reabsorbed less effectively by the terminal ileum in elderly subjects compared 
to younger ones. As a result of increased spill-over into the colon bacterial 
dehydroxylation of cholic acid into deoxycholic acid may be increased. An 
increased exposure of deoxycholic acid to the colonic mucosa may contribute 
to an enhanced risk of colorectal cancer since secondary bile acids are 
thought to have co-carcinogenic effects on the colonic mucosa. 
In order to find further evidence that ageing influences bile acid reabsorp-
tion in the small intestine, fasting and postprandial conjugated and unconju-
gated serum bile acid levels were measured in twelve young adults and twelve 
elderly subjects. Serum bile acid levels were measured by capillary gas-liquid 
chromatography, a highly accurate and sensitive method for individual bile 
acids (cholic, chenodeoxycholic, deoxycholic and ursodeoxycholic acid) ana-
lysis. 
In the elderly subjects postprandial levels of conjugated bile acids incre-
ased to a lesser extent than in the younger subjects. This suggests that active 
ileal absorption of conjugated bile acids is less effective in elderly subjects. 
Unconjugated deoxycholic acid levels tended to be higher in elderly subjects, 
although the difference did not reach statistical significance. The observed 
differences between both age groups could not be explained by delayed gal-
lbladder emptying, impaired intestinal motility, nor by small intestinal bacte-
rial overgrowth, since gallbladder emptying, intestinal transit time, and 
small intestinal flora were similar in both groups. 
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Chapter 5 — Small intestinal bacterial overgrowth is associated with steator-
rhoea, as a result of bacterial deconjugation of bile acids. Previous studies 
have shown that unconjugated serum bile acid levels are usually increased in 
patients with small intestinal bacterial overgrowth. However, it is unclear 
whether other causes of malabsorption, such as coeliac disease and exocrine 
pancreatic insufficiency, can be differentiated from small intestinal bacterial 135 
overgrowth on the basis of a characteristic serum bile acid profile. 
In chapter 5 the results are reported of a study on unconjugated serum bile 
acid levels in patients with small intestinal bacterial overgrowth or other cau-
ses of malabsorption, such as untreated coeliac disease and exocrine pancre-
atic insufficiency. A group of healthy volunteers and a group of patients who 
had undergone ileal resection without evidence of malabsorption served as 
controls. The latter group was included since ileal resection may lead to eleva-
ted unconjugated serum bile acid levels as a result of spill-over and deconju-
gation in the colon. Moreover, a group of patients who had undergone proc-
tocolectomy with ileal pouch-anal anastomosis was investigated since stasis 
in the ileal pouch may lead to bile acid deconjugation. It was shown that fas-
ting unconjugated serum bile acid levels are significandy increased in 
patients with small intestinal bacterial overgrowth when compared to healthy 
volunteers, patients with other causes of malabsorption, and ileal pouch-anal 
anastomosis patients. Patients with ileal resection had elevated unconjugated 
primary bile acid levels and decreased unconjugated deoxycholic acid levels. 
The sensitivity and specificity of total unconjugated serum bile acid levels as a 
marker for small intestinal bacterial overgrowth in patients with malabsorp-
tion were 82% and 100% respectively. 
Chapter 6 — This chapter describes the effects of proctocolectomy with ileal 
pouch anal anastomosis on serum bile acid levels. Eleven pouch patients and 
11 sex and age matched healthy subjects participated in this study. Fasting 
levels of conjugated deoxycholic acid but not cholic and chenodeoxycholic 
acid were significantly lower in the pouch patients. Postprandial^, conjuga-
ted bile acid levels were significandy lower in the pouch patients. Deoxycholic 
acid levels were decreased to a much lower extent compared to the primary 
bile acids, cholic and chenodeoxycholic acid. Postprandial unconjugated 
cholic acid levels were significantly higher and chenodeoxycholic acid levels 
tended to be higher, whereas unconjugated deoxycholic acid levels were 
significantly lower in the pouch patients. These data suggest that reabsorp-
tion of conjugated bile acids is impaired after proctocolectomy with ileal 
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pouch-anal anastomosis. Stasis in the pouch may lead to deconjugation of 
bile acids as a result of bacterial overgrowth. Dehydroxylation however, is 
decreased after proctocolectomy with ileal pouch-anal anastomosis, prob-
ably as a result of the absence of the colon. 
Chapter 7 — Previous studies have shown that the colon and rectum contain 
regulatory peptides in mucosal endocrine cells which suggests a hormonal 
role. It has been demonstrated that colonic perfusion with nutrients inhibits 
pancreatic enzyme secretion and the release of cholecystokinin. Moreover, it 
has been shown that subtotal colectomy results in an increased postprandial 
cholecystokinin release in rats and dogs. These findings suggest that the 
colon contains a factor that suppresses the release of cholecystokinin. Litde 
is known however, about the effects of proctocolectomy on gastrointestinal 
physiology and circulating gut hormone responses in humans. 
Chapter 7 describes the effects of proctocolectomy with ileal pouch-anal 
anastomosis on fasting, postprandial, and bombesin stimulated plasma cho-
lecystokinin levels and gallbladder volumes. Twelve healthy volunteers and 
ten patients who had undergone proctocolectomy with ileal pouch-anal ana-
stomosis participated in this study. Fasting and postprandial cholecystokinin 
levels were significantly higher in the pouch patients. Fasting gallbladder 
volumes were significandy decreased in the ileal pouch patients, probably as 
a result of fasting hypercholecystokininaemia. Postprandial gallbladder emp-
tying was similar in both groups. In a second experiment it was demonstrated 
that intravenous administration of bombesin results in higher plasma chole-
cystokinin levels in ileal pouch patients compared to healthy controls. These 
findings suggest that the human colon contains a factor that inhibits the rele-
ase of cholecystokinin. However, it could not be excluded that interruption of 
the enterohepatic circulation after proctocolectomy with ileal pouch-anal 
anastomosis plays a role in the increased release of cholecystokinin. 
Chapter 8 — Interruption of the enterohepatic circulation by ileal resection 
leads to bile acid malabsorption and spill-over of bile acids into the colon. 
This is associated with increased faecal bile acid losses and a decreased duo-
denal bile acid output. Since intraduodenal bile acids exert an inhibitory 
effect on the release of cholecystokinin, ileal resection might increase chole-
cystokinin levels. To test this hypothesis we measured fasting and postpran-
dial serum bile acids, plasma cholecystokinin, and gallbladder volumes in 
eight patients who had undergone ileal resection for Crohn's disease and in 
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twelve healthy volunteers. The results of this study are presented in chapter 8. 
Not surprisingly, postprandial conjugated serum bile acid levels were 
decreased in the patients with ileal resection. However, plasma cholecysto-
kinin levels and gallbladder volumes were similar in both groups. These data 
suggest that elevated plasma cholecystokinin levels after proctocolectomy are 
not the result of interruption of the enterohepatic circulation. 137 
Patients with Crohn's disease, particularly those with a history of distal 
ileitis or ileal resection, have an increased risk for cholelithiasis, possibly as a 
result of a decreased bile acid pool and a subsequent increase of biliary cho-
lesterol saturation. However, various data on bile lithogenicity in patients 
with Crohn's disease have been published. Recently, Swedish investigators 
have found a low biliary cholesterol saturation and a more than tenfold incre-
ase in the relative concentration of biliary ursodeoxycholic acid after ileal 
resection. 
In order to examine whether ileal resection leads to alterations in bile acid 
absorption, deconjugation, 7a-dehydroxylation, and formation of urso-
deoxycholic acid, fasting and postprandial individual conjugated and uncon-
jugated serum bile acid levels were measured in both groups. As expected, 
postprandial conjugated bile acid levels were decreased after ileal resection. 
Deoxycholic acid levels were extremely low after ileal resection, probably as a 
result of rapid colonic transit and shortened exposure to bacterial ja-de-
hydroxylation. Unconjugated cholic and chenodeoxycholic acid levels were 
increased after ileal resection. Spill-over of conjugated bile acids into the 
colon leads to increased deconjugation and increased reabsorption of uncon-
jugated bile acids. Ursodeoxycholic acid was present in the serum of six of the 
eight patients with ileal resection but in none of the healthy volunteers. This 
is probably due to malabsorption of chenodeoxycholic acid, which is in part 
converted into ursodeoxycholic acid in the colon. 
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Samenvatting 
Sinds het begin van de jaren tachtig wordt de ileo-anale pouch procedure 
steeds meer toegepast als alternatief voor colectomie met ileostoma bij patin-
ten met colitis ulcerosa of familiaire adenomateuze polyposis. Bij deze opera- 139 
tie wordt, nadat het gehele colon is verwijderd, een reservoir -de pouch-
geconstrueerd van het terminale ileum. Deze pouch wordt ingehecht op de 
anus met behoud van het sfincter-mechanisme. Het voordeel van deze opera-
tie is dat de patiënt geen (definitief) stoma nodig heeft, terwijl toch het gehele 
colon, dat ernstig ziek is, kan worden verwijderd. 
Hoofdstuk 2 — In Hoofdstuk 2 wordt een overzicht gegeven van de literatuur 
op het gebied van de ileo-anale pouch procedure. Allereerst worden de meest 
voorkomende postoperatieve complicaties zoals ileus, naadlekkage, naad-
dehiscentie en sepsis besproken. Vervolgens wordt een overzicht gegeven 
van de resultaten op de lange termijn, waarbij de nadruk ligt op functionele 
aspecten zoals de defecatie frequentie en de mate van continentie. Aan de 
hand van een aantal vergelijkende studies wordt aangetoond dat het resultaat 
van de ileo-anale pouch operatie meestal beter is bij polyposis patiënten dan 
bij colitis patiënten. Verder zal kort worden ingegaan op de verschillende 
reservoir typen (J-, W-, en S-pouch). 
Recente chirurgische ontwikkelingen, zoals het gebruik van nieuwe hecht-
technieken (stapler apparatuur), en daarmee samenhangend, het achterwege 
laten van het tijdelijk ondastend dubbelloops ileostoma, hebben er de laatste 
jaren toe geleid tot dat de procedure in één stap kan worden uitgevoerd. Voor-
heen was een tweede operatie, en dus een tweede ziekenhuisopname, nood-
zakelijk om het dubbelloops ileostoma op te heffen. Deze ingreep ging vaak 
gepaard met ernstige complicaties zoals ileus. 
De belangrijkste complicatie van de ileo-anale pouch procedure op lange 
termijn is pouchitis. Pouchitis is een aspecifieke ontsteking van het ileum-
slijmvlies in de pouch, met een sterke neiging tot recidiveren. Klinische 
verschijnselen van pouchitis zijn: toename van de defecatiefrequentie, bloed-
verlies bij de ontlasting, buikpijn, algehele malaise, en koorts. Daarnaast 
kunnen ook extraintestinale klinische verschijnselen optreden zoals artritis 
en erythema nodosum. De oorzaak van pouchitis is onbekend. Men veron-
derstelt dat stase van darminhoud in de pouch kan leiden tot bacteriële over-
groei en daardoor tot ontsteking van het slijmvlies. Deze hypothese wordt 
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gesteund door het feit dat behandeling met metronidazol, een antibioticum 
dat gericht is tegen anaërobe bacteriën, vaak een gunstig effect heeft. Het is 
opvallend dat pouchitis alleen lijkt voor te komen bij colitis patiënten en niet 
bij polyposis patiënten. Dit suggereert dat colitis en pouchitis een gemeen-
schappelijke Pathogenese hebben. 
Ten slotte worden in dit hoofdstuk een aantal fysiologische aspecten van 
de ileo-anale pouch procedure besproken, zoals veranderingen in het gal-
zuurmetabolisme, de water- en zouthuishouding en de motiliteit van maag 
en dunne darm. 
Hoofdstuk 5 — In dit hoofdstuk wordt een overzicht gegeven van de postope-
ratieve complicaties en de functionele resultaten op lange termijn bij alle 
patiënten (51 colitis ulcerosa en 21 familiaire adenomateuze polyposis 
patiënten) die tussen 1983 en 1990 in het St. Radboud Ziekenhuis een ileo-
anale pouch-operatie ondergingen. Aangezien colitis ulcerosa patiënten ten 
tijde van de operatie meestal corticosteroiden gebruiken en in een slechtere 
lichamelijke conditie verkeren dan polyposis patiënten werden de resultaten 
in beide groepen met elkaar vergeleken. Uit dit onderzoek bleek dat de inci-
dentie van postoperatieve complicaties, waarvoor een relaparotomie noodza-
kelijk was, niet significant verschilde tussen beide groepen. Pouchitis was de 
belangrijkste complicatie op de lange termijn en kwam voor bij 44% van de 
colitis patiënten maar niet bij de polyposis patiënten (p<o.oo5). De pouch 
moest worden verwijderd bij 11 (22%) colitis patiënten en bij één (5%) poly-
posis patiënt (p=o.i6). Bij zes colitis patiënten werd de pouch verwijderd in 
verband met pouchitis. De defecatiefrequentie na ileo-anale anastomose was 
significant hoger bij colitis patiënten dan bij polyposis patiënten. Incontinen-
tie overdag kwam zelden voor. Gedurende de nacht waren 16 (43%) van de 
colitis patiënten en zes (32%) van de polyposis patiënten in meer of mindere 
mate incontinent (niet significant). Zestien polyposis patiënten (76%) en 22 
colitis patiënten (46%) waren uiteindelijk zeer tevreden met hun pouch 
(p<o.o5). 
Hoo/dstuk 4 — In hoofdstuk 4 wordt de invloed van leeftijd op de concentratie 
van galzuren in serum beschreven. Uit eerder onderzoek is gebleken dat de 
vorming van deoxycholzuur bij oudere mensen is toegenomen. Een verkla-
ring hiervoor zou kunnen zijn dat cholzuur bij ouderen minder effectief 
wordt gereabsorbeerd in het terminale ileum dan bij jongeren. Door bacterië-
le enzymen wordt het cholzuur, dat niet in het terminale ileum is gereabsor-
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beerd, in het colon gedeconjugeerd en vervolgens omgezet in deoxycholzuur 
(7a-dehydroxylatie). Er zijn aanwijzingen dat secondaire galzuren zoals 
deoxycholzuur een co-mutageen effect hebben op de colonmucosa. Het is 
derhalve mogelijk dat een afgenomen galzuurreabsorptie in het terminale 
ileum bij ouderen bijdraagt tot een toegenomen risico op coloncarcinoom. 
In de studie beschreven in dit hoofdstuk werden nuchtere en postprandia- 141 
Ie geconjugeerde en ongeconjugeerde galzuur concentraties in serum geme-
ten bij twaalf jongere en twaalf oudere gezonde vrijwilligers. De galzuren 
werden gemeten met behulp van capillaire gaschromatografie, een gevoelige 
methode waarmee het mogelijk is de lage serumconcentraties van de indivi-
duele galzuren (cholzuur, chenodeoxycholzuur, deoxycholzuur en urso-
deoxycholzuur) nauwkeurig te meten. Het bleek dat de geconjugeerde gal-
zuur concentratie in serum na een maaltijd bij ouderen significant lager was 
dan bij jongere personen. Dit suggereert dat het terminale ileum bij jongere 
mensen beter in staat is galzuren te reabsorberen dan bij oudere mensen. De 
verschillen tussen beide groepen konden niet worden verklaard door ver-
schillen in darmpassagetijd, galblaasontlediging of dunne darmflora, aange-
zien deze parameters niet verschilden tussen beide groepen. Verder bleek dat 
de concentratie van ongeconjugeerd deoxycholzuur bij oudere mensen hoger 
was dan bij jongeren, ook al was dit verschil niet statistisch significant 
(p=o.oo). Een afgenomen reabsorptie van cholzuur in het terminale ileum bij 
ouderen zou dit verschil, evenals de verhoogde vorming van deoxycholzuur 
bij ouderen, kunnen verklaren. 
Hoofdstuk 5 — Bacteriële overgroei in de dunne darm gaat meestal gepaard 
met steatorrhoe. Deconjugatie van galzuren door bacteriële enzymen in de 
dunne darm speelt hierbij een belangrijke rol omdat ongeconjugeerde 
galzuren veel minder goed in staat zijn vet te emulgeren dan geconjugeerde 
galzuren. Uit eerder onderzoek is gebleken dat de concentratie van ongecon-
jugeerde galzuren in serum vaak verhoogd is bij patiënten met bacteriële 
overgroei in de dunne darm. Het is echter niet goed bekend of ook andere 
oorzaken van malabsorptie, zoals coeliakie en exocriene pancreasinsufficiën-
tie, gepaard gaan met verhoogde ongeconjugeerde serum galzuur concentra-
ties. Ook is niet bekend of deze aandoeningen op grond van een kenmerkend 
profiel van individuele galzuren van elkaar te onderscheiden zijn. 
In hoofdstuk 5 wordt beschreven wat de waarde is van het bepalen van 
ongeconjugeerde serum galzuur concentraties voor de diagnostiek van bacte-
riële overgroei in de dunne darm en voor de differentiële diagnostiek van 
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malabsorptie. Hiertoe werden nuchtere individuele serum galzuur concen-
traties gemeten bij gezonde vrijwilligers, patiënten met bacteriële overgroei, 
patiënten met onbehandelde coeliakie en patiënten met exocriene pancreas-
insufficiëntie. Tevens werd een aantal patiënten onderzocht die een ileocae-
caalresectie hadden ondergaan omdat spill-over van geconjugeerde galzuren 
naar het colon kan leiden tot een toegenomen deconjugatie en verhoogde 
ongeconjugeerde serum galzuur concentraties. Ook werd een aantal patiën-
ten met een ileo-anale pouch onderzocht omdat stase in de pouch kan leiden 
tot bacteriële overgroei en deconjugatie van galzuren. 
In deze studie bleek dat nuchtere ongeconjugeerde serum galzuur concen-
traties significant verhoogd zijn bij patiënten met bacteriële overgroei in 
vergelijking met gezonde vrijwilligers, patiënten met coeliakie, patiënten met 
exocriene pancreasinsufficiëntie en patiënten met een ileo-anale anastomo-
se. Patiënten die een ileocaecaalresectie hadden ondergaan hadden verhoog-
de primaire ongeconjugeerde galzuur concentraties in serum, terwijl de 
concentratie van deoxycholzuur juist verlaagd was. 
De specificiteit en sensitiviteit van ongeconjugeerde totale serum galzuur 
concentraties als een marker voor bacteriële overgroei in de dunne darm bij 
patiënten met malabsorptie waren respectievelijk 82% en 100%. 
Hoofdstuk 6 — In dit hoofdstuk worden de resultaten beschreven van een stu-
die waarin het effect van proctocolectomie met ileo-anale anastomose op het 
galzuurmetabolisme werd onderzocht. Hiertoe werden nuchtere en post-
prandiale geconjugeerde en ongeconjugeerde serum galzuur concentraties 
gemeten bij elf patiënten met een ileo-anale anastomose en bij elf gezonde 
vrijwilligers. Beide groepen kwamen qua leeftijd en geslacht nauwkeurig met 
elkaar overeen. Na de maaltijd bleken de geconjugeerde galzuur concentra-
ties significant lager te zijn bij de ileo-anale pouch patiënten. De deoxychol-
zuur concentratie was relatief veel sterker verlaagd dan die van de primaire 
galzuren. De concentratie van ongeconjugeerd cholzuur was significant 
hoger, terwijl de concentratie van ongeconjugeerd deoxycholzuur significant 
lager was bij de ileo-anale pouch patiënten. Deze gegevens suggereren dat de 
reabsorptie van geconjugeerde galzuren verminderd is na proctocolectomie 
met ileo-anale anastomose en dat stase in de pouch leidt tot deconjugatie van 
galzuren, waarschijnlijk ten gevolge lokale bacteriële overgroei. Door het 
ontbreken van het colon is de omzetting van cholzuur in deoxycholzuur sterk 
afgenomen bij deze patiënten. 
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Hoofdstuk 7 — Uit eerder onderzoek is gebleken dat in de mucosa van het 
colon endocriene cellen voorkomen, waarin bepaalde hormonen zoals pepti-
de-YY en enteroglucagon, worden gevormd. De functie van deze peptiden is 
niet goed bekend. Wel is aangetoond dat perfusie van het colon met bepaalde 
nutriënten, een remmend effect heeft op de afgifte van cholecystokinine en 
de secretie van pancreasenzymen. Bij ratten en honden is bovendien aange- 143 
toond dat colectomie leidt tot verhoogde postprandiale cholecystokinine 
spiegels in het bloed. Deze bevindingen suggereren dat het colon een factor 
bevat, die een remmend effect heeft op de afgifte van cholecystokinine uit het 
proximale deel van de dunne darm, en dat deze factor geactiveerd kan worden 
door de mucosa van het colon bloot te stellen aan bepaalde stoffen. Het is 
echter onbekend wat het effect is van (procto)colectomie op de afgifte van 
cholecystokinine bij de mens. 
In hoofdstuk 7 worden de resultaten beschreven van een studie waarin het 
effect werd onderzocht van proctocolectomie op de afgifte van cholecystoki-
nine en de galblaasmotiliteit bij de mens. Dit onderzoek werd uitgevoerd bij 
twaalf gezonde vrijwilligers en tien patiënten die een proctocolectomie met 
ileo-anale anastomose hadden ondergaan. In deze studie bleek dat de nuch-
tere en postprandiale cholecystokinine spiegels significant hoger waren bij 
de ileo-anale pouch patiënten dan bij de gezonde vrijwilligers. Bovendien was 
het nuchtere galblaasvolume significant kleiner bij deze patiënten, 
waarschijnlijk als gevolg van de verhoogde basale cholecystokinine spiegels. 
De galblaas ontlediging was vergelijkbaar in beide groepen. In een tweede 
experiment werd aangetoond dat ook tijdens intraveneuze toediening van 
bombesine, een peptide dat de afgifte van cholecystokinine stimuleert, de 
cholecystokinine spiegels significant hoger waren bij de ileo-anale pouch 
patiënten. Deze gegevens suggereren dat ook het humane colon endocriene 
eigenschappen bezit, en dat de afgifte van cholecystokinine geremd wordt 
door een factor die afkomstig is uit het colon. Het is echter niet met zekerheid 
uit te sluiten dat onderbreking van de enterohepatische kringloop een rol 
speelt bij de verhoogde cholecystokinine spiegels na proctocolectomie met 
ileo-anale anastomose. 
Hoofdstuk 8 — Resectie van het terminale ileum leidt tot onderbreking van de 
enterohepatische kringloop en gaat gepaard met een toegenomen fecaal 
galzuurverlies en een verminderde output van galzuren in het duodenum. 
Aangezien galzuren in het duodenum een remmende invloed hebben op de 
afgifte van cholecystokinine is het in theorie mogelijk dat cholecystokinine 
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spiegels verhoogd zijn na resectie van het terminale ileum. Om deze hypothe-
se te onderzoeken werden bij acht patiënten, die in verband met de ziekte van 
Crohn een ileocaecaalresectie hadden ondergaan, en bij twaalf gezonde 
vrijwilligers nuchtere en postprandiale galzuur en cholecystokinine concen-
traties en galblaasvolumina gemeten. Zoals te verwachten waren de post-
prandiale geconjugeerde galzuur concentraties duidelijk verlaagd bij de 
patiënten die een ileum resectie hadden ondergaan. De plasma cholecystoki-
nine spiegels en het galblaasvolume werden echter niet beïnvloed door resec-
tie van het terminale ileum. Dit maakt het onwaarschijnlijk dat de verhoogde 
cholecystokinine spiegels na proctocolectomie veroorzaakt worden door 
onderbreking van de enterohepatische kringloop. 
Uit verschillende studies is gebleken dat patiënten die een ileocaecaalre-
sectie hebben ondergaan een verhoogd risico hebben op galstenen. Dit zou 
verklaard kunnen worden door een afname van de biliaire galzuur concentra-
tie als gevolg van de onderbroken enterohepatische kringloop. Een afname 
van de galzuur concentratie in gal leidt tot een toename van de lithogene 
index. Studies naar de lithogeniciteit van gal na ileumresectie hebben echter 
tegenstrijdige gegevens opgeleverd. Recent vonden Zweedse onderzoekers 
dat na resectie van het terminale ileum de lithogene index juist verlaagd is - in 
tegenstelling tot eerdere studies van andere onderzoekers - en dat de relatieve 
biliaire concentratie van ursodeoxycholzuur, dat een gunstig effect heeft op 
de lithogene index, bij deze patiënten sterkverhoogd is. 
Om de invloed van ileumresectie op deconjugatie, dehydroxylatie en de 
vorming van ursodeoxycholzuur te bestuderen werden nuchtere en postpran-
diale individuele geconjugeerde en ongeconjugeerde serum galzuur concen-
traties gemeten in beide groepen. De geconjugeerde serum galzuur concen-
traties waren duidelijk verlaagd na ileumresectie. De concentratie van deoxy-
cholzuur was veel sterker verlaagd dan die van de primaire galzuren. Dit is 
waarschijnlijk het gevolg van een versnelde passage door het colon met een 
verkorte blootstelling aan bacterieel 7Cc-dehydroxylase. De ongeconjugeerde 
cholzuur en chenodeoxycholzuur concentraties waren verhoogd na ileumre-
sectie. Spill-over van geconjugeerde galzuren naar het colon leidt tot een toe-
genomen deconjugatie en verhoogde resorptie van ongeconjugeerde galzu-
ren. Ursodeoxycholzuur was aantoonbaar in het serum van zes van de acht 
patiënten die een ileumresectie hadden ondergaan, maar niet bij de gezonde 
vrijwilligers. Waarschijnlijk is dit het gevolg van malabsorptie van geconju-
geerd chenodeoxycholzuur omdat chenodeoxycholzuur in het colon door 
bacteriële enzymen omgezet kan worden in ursodeoxycholzuur. 
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CLINICAL AND PHYSIOLOGICAL 
ASPECTS OF ILEAL POUCH-ANAL 
ANASTOMOSIS 
Stellingen 
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I 
Pouchitis komt alléén voor bij colitis patiënten en niet bij polyposis 
patiënten. Dit suggereert dat pouchitis een nieuwe manifestatie is van 
colitis ulcerosa. 
— DIT PROEFSCHRIFT 
2 
Een afgenomen absorptie van geconjugeerde galzuren in het terminale 
ileum bij oudere mensen leidt tot een toegenomen expositie van 
secundaire galzuren aan hetcolonslijmvlies. Dit kan bijdragen aan een 
verhoogde kans op coloncarcinoom op hogere leeftijd. 
— DIT PROEFSCHRIFT — 
3 
Verhoogde ongeconjugeerde serum galzuurspiegels zijn een zeer 
specifieke marker voor bacteriële overgroei in de dunne darm mits 
het terminale ileum intact is. 
— DIT PROEFSCHRIFT — 
4 
Proctocolectomie met ileo-anale pouch anastomose leidt tot onder-
breking van de enterohepatische kringloop van galzuren en tot een 
verminderde omzetting van primaire in secundaire galzuren. 
DIT PROEFSCHRIFT 
5 
Cholecystokininespiegels in plasma zijn verhoogd na proctocolectomie. 
Dit wordt waarschijnlijk niet veroorzaakt door onderbreking van de 
enterohepatische kringloop, maar door het wegvallen van een factor, 
afkomstig uit het colon, die de afgifte van cholecystokinine remt. 
— DIT PROEFSCHRIFT—· 
6 
Captopril kan waarschijnlijk acute pancreatitis veroorzaken 
— EIGEN WAARNEMING — 
7 
Het is zeer twijfelachtig of patiënten met een short bowel syndroom, die 
volledig afhankelijk zijn van totale parenterale voeding, met een dunne 
darmtransplantatie beter af zouden zijn. 
8 
Het feit dat de vooruitgang op medisch therapeutisch gebied geen gelijke 
tred houdt met de snelle ontwikkelingen op het gebied van de medische 
diagnostiek wordt in de media onvoldoende belicht. 
9 
Het spreekwoord: "Beter één vogel in de hand dan tien in de lucht" 
voldoet niet meer aan de huidige ecologische inzichten en zou thans 
moeten luiden: "Beter tien vogels in de lucht dan één in de hand". 
io 
Omdat improvisatie de essentie vormt van de jazz sterft de muziek van een 
jazzmusicus met zijn overlijden. 
ir 
Zonder testosteron zou het een stuk rustiger zijn in de voetbalstadions, 
en waarschijnlijk ook daarbuiten. 
12 
De voorspellingen over de klimatologische veranderingen zijn net zo 
veranderlijk als het weer zelf. 



